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INTRODUCTION 
Clinical shock is a complex pathophysiological process. In 1892, 
Samuel Gross defined shock as "a rude unhinging of the machinery of 
life". Although his definition is still valid, a more current 
definition would define shock as an altered physiological state 
characterized by a decreased effective blood volume. This loss of 
effective blood volume may be caused by various mechanisms. Examples of 
these mechanisms include blood loss, loss of smooth muscle tone, or a 
hypoeffective heart. The body's ability to maintain blood pressure and 
adequate cardiac output is impaired which compromises adequate perfusion 
of tissues and ultimately leads to cell damage and death. 
Shock has been classified into categories based on the primary 
cause of the altered state. These common categories include endotoxic, 
hemorrhagic, neurogenic, and burn shock. Each form of shock may be 
initiated by altered function in one body area or organ but all may 
progress to a systemic derangement of multiple functions and failure to 
maintain tissue perfusion. When sufficient function has been altered, 
the body can no longer compensate and a state of irreversible shock and 
eventual death occurs. Physiologists and clinicians continue to debate 
the role of various mechanisms in this irreversible state and especially 
the role of peripheral versus central collapse of the cardiovascular 
system. Is the depressed myocardial function observed in shock 
secondary to deranged peripheral vascular or microvascular collapse or 
does impaired myocardial function fail to sustain adequate peripheral 
perfusion pressure? Both processes can initiate positive feedback 
2 
circuits and ultimately produce a state of irreversible shock. 
Cardiac failure in terminal shock is widely accepted, but the role 
of central failure earlier in the process is controversial. Excellent 
reviews of the role of the myocardium in shock have been written by 
Lefer (1974,1979), Hess et al. (1985), and Okada et al. ( 198'j). Wiggers 
and Werle (1942) first reported and Crowell and Guyton (1961, 1962) 
later confirmed that cardiac performance decreases with time during 
severe hypotension. Crowell and Guyton established the shifts in 
ventricular function curves during hemorrhagic shock which have been 
interpreted as a progressive impairment of myocardial contractility. As 
the duration of shock increased, atrial pressure increased while cardiac 
output progressively declined. 
Functional and morphological changes in the myocardial cell in 
shock are well-documented. An in-depth review of the morphological 
changes is not appropriate to this paper. However, Martin and Hackel 
(1966) and Hackel et al. (1974) have reported typical changes which 
include mitochondrial displacement, nypercontraction of the sarcomeres, 
fragmentation of the Z-bands, and abnormal organization of the 
myofilaments. 
Hemorrhagic shock has been reported by Forrester et al. (1972) to 
decrease pump performance but not necessarily alter the maximum velocity 
of contraction which is a measure of contractility. Significant 
reduction of both stroke volume and cardiac output was reported by 
Siegel and Downing (1970) and Forrester et al. (1972) but no long-term 
effects on either heart rate or left ventricular end diastolic pressure 
were observed. Goldfarb (1982) and Downing (1933) have reviewed many of 
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the functional changes in shock. The subcellular function of cardiac 
tissue has also been reviewed by Hess and Krause (1979)' 
Cardiac failure in shock has been attributed to many different 
factors. The list of these factors includes acidosis, decreased 
coronary blood flow, the effects of clotting factors which cause 
'sludging of blood', hypoxia, altered hormone function, and the 
production of endogenous factors which depress myocardial function. 
The role of these endogenous factors has been very controversial. 
Several excellent reviews of shock factors have been published by Lefer 
(1973, 1978, 1979), Goldfarb (1979), and Haglund (1983). Haglund has 
defined a shock toxin as a substance that is released into the general 
circulation in shock and which then exerts a deleterious effect on the 
body. These substances are produced in specific regions or tissues in 
the body and enter the systemic circulation via the lymphatics or 
directly into the blood. They are transported to and interact at the 
target organ(s) where they alter function. Examples of lost function 
include loss of smooth muscle tone and impaired myocardial contractility 
which lead to peripheral vasculature collapse and decreased cardiac 
output, respectively. 
Haglund has proposed four criteria necessary for defining a shock 
toxin. First, there should be no production of the substance in a 
healthy individual. It .must be possible to isolate and identify the 
unique biochemical composition. Isolated material from a shock 
individual must produce toxic effects in a healthy individual. Finally, 
a shock toxin should be common to multiple categories of shock. 
Myocardial depressant factor (MDF) is the best known and most 
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extensively studied of these shock factors. UDF was first described by 
Brand and Lefer (1966). It has been found in all types of shock in the 
plasma of virtually all species which have been evaluated, as reported 
by Lefer (1974). Lefer and Spath (1974) have shown that MDF is produced 
in shock as blood flow to the pancreas is compromised. Ferguson et al. 
(1972) have shown that all of the necessary constituents for production 
are present in the pancreas. The MDF is released by the pancreatic 
cells when sufficient insult of shock is present. The MDF is 
transported either via the lymphatic channels or enters the circulation 
directly. 
There have been three identified effects of MDF on systemic 
function. First, Lefer (l970) reported a negative inotropic effect 
which was measured as depressed peak developed tension by feline 
papillary muscles. Glucksman and Lefer (1971) subsequently observed a 
pronounced vasoconstrictor effect of strips of the superior mesenteric 
artery but not other central and peripheral vessels. Finally, Lefer and 
Blattberg (1968) reported that MDF inhibited the phagocytic activity of 
fixed macrophages in the liver. The three effects all contribute to a 
positive feedback phenomenon which may ultimately contribute to 
irreversible shock. As cardiac output falls, the pancreas becomes 
hypoperfused and MDF is formed. It is released into the circulation 
where it further depresses cardiac output and causes a potent 
constriction of the vasculature which nourishes the pancreas. This 
further compromises pancreatic blood flow. Inhibition of the 
macrophagic activity may prevent clearance or reduction in the levels of 
MDF. 
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MDF has not been completely purified but has been separated by gel 
chromatography and is believed to have a molecular weight between 
500-1000, as reported by Lefer and Martin (1970). Green et al. (1977) 
have determined that the material is a peptide composed of glycine, 
serine, glutamic acid, and an unidentified fourth molecule. Although 
Lefer (1970) reported only nanogram levels in the plasma during shock, 
the negative inotropic effects have been consistently observed and are 
potent. The inotropic effect of MDF has been reported by Lefer and 
Rovetto (1970) to be independent of an effect on either resting membrane 
potential or the amplitude of the action potential. They did observe a 
longer duration of the action potential and reported that excess calcium 
can antagonize the effects of MDF. 
There has been substantial confirmation of MDF and reports of 
MDF-like activity by others. Rogel and Hilewitz (1978) have correlated 
in vivo and in vitro changes believed to be caused by MDF. Fisher et 
al. (1973) established a dose response curve for MDF which was 
approximately linear. Manning et al, (1980) measured MDF levels in ante 
and postmortem blood of trauma and disease victims. Levels were 
increased in those patients with compromised pancreatic blood flow or 
pancreatitis. The plasma concentration increased in the terminal stages 
of life. Lee et al. (1981 ) observed depressed myocardial function in 
patients with acute pancreatitis and postulated that this response was 
due to MDF. Their study emphasizes the potential role of a depressant 
factor in disease processes other than shock. 
The evidence for a role of MDF is very strong. However, attempts 
to confirm the presence of MDF or central cardiac depression in other 
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laboratories have not always been successful. Hinshaw (l979) has 
reviewed the extensive studies undertaken in his laboratory to detect 
depressed myocardial function in response to endotoxin shock or 
occlusion of the superior mesenteric artery (SHA). Despite total 
occlusion of the SMA or 20 hours of endotoxin shock, no depression could 
be detected. His methods often employed cross-perfusion of a working 
but isolated heart where temperatures less than 57 C might be expected. 
Wilson et al. (1973) assessed dialysates of serum obtained from 
hypotensive dogs with rabbit papillary muscles. No depression in the 
peak tension or rate of development was observed. Neither their methods 
for dialysis nor for the bioassay system were described. Differences in 
methods could have accounted for their observation. Chiraoskey and Bohr 
(1965) compared the myocardial performance of papillary muscles from 
rats subjected to hemorrhagic shock and from control rats. iJo impaired 
contractility was observed. However, their muscles were not tested in 
the shock plasma and MDF effects are known to be at least partly 
reversible. Adams et al. (1981) evaluated atrial muscle from burned 
guinea pigs for changes in contractility. Again, no change in isometric 
tension was produced but the rate of relaxation was significantly 
impaired. The experimentation was conducted at 30 C. Urschel et al. 
(1972) evaluated both fresh shock plasma and the effects of endotoxin on 
feline papillary function at conditions of 30 C and a frequency of 
12/minute. No depression was observed. 
Repeated efforts were made in our laboratory over a two year period 
to identify and evaluate MDF. Occasionally, a depressant was observed. 
After reviewing the literature it was noted that negative findings were 
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associated with methods that differed markedly from the protocols of 
Lefer. Our bioassay preparation was unique in several respects. Young 
canine papillary muscles were used with an isotonic preparation at 21 C 
and a stimulus frequency of 12/minute. Lefer had utilized feline 
muscles contracting isometrically at C and a frequency of 50/minute. 
It was felt that species, age, and type of contraction were the least 
likely factors to obscure a depressant action. If conditions of 
temperature or frequency could alter muscle responsiveness to the 
depressant, then that observation might help to reconcile the 
controversy concerning MDF. 
The following studies were conducted. First, a study was conducted 
to confirm the presence of an endogenous depressant in the plasma of 
canines in hemorrhagic shock. Although prior studies have evaluated riDF 
effects in the intact dog, none had confirmed the effects on isolated 
canine papillary muscle. Second, the production and presence of a 
depressant in homogenates of pancreas were evaluated. The final studies 
were conducted to assess the effects of temperature and frequency on 
cardiac muscle function and on the response of the muscle to the 
endogenous depressant. 
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PRODUCTION AND BIOASSAY OF A MYOCARDIAL DEPRESSANT IN SHOCK PLASMA 
Introduction 
The role of a myocardial depressant substance in shock remains 
controversial. Considerable information has been published on the 
various parameters, such as cardiac output, blood pressures, oxygen 
consumption, etc., which are altered in a shock state. However, 
extensive physiological information was not reported in the previous 
studies on MDF by Lefer (1973, 1974, 1979) and Goldfarb et al. (1979). 
The evidence accumulated by Lefer and others for MDF is strong and 
extensive, yet in independent studies by Coleman et al. (1975), Hinshaw 
(1979), Urschel et al. (1972) and Wilson et al. (1973), myocardial 
depression or indications of central cardiac failure have not been 
detected until very late in shock. These different conclusions reported 
by the investigators may have been due to variation in the procedure to 
generate the depressant. Therefore, a well-defined model in which dogs 
were subjected to hemorrhagic shock, was initially chosen to evaluate 
the role of an endogenous depressant substance in shock. The specific 
protocol for the production of the depressant in these experiments was 
similar to that previously reported by Lefer and Martin (l970) and based 
on the model of Wiggers (1950). The techniques employed in assaying 
depressant activity are either widely accepted in the literature or have 
been previously reported for in vitro assessment of myocardial function 
by Hembrough et al. (1978) and Hembrough et al. (198O). However, the 
canine derived depressant was bioassayed on isolated canine myocardium 
contracting isotonically. The methods employed also enabled examination 
of muscle function over a range of afterloads and assessment of 
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of relaxation velocities and intervals of time in the contractile cycle 
in addition to maximum load. Only limited studies by Kembrough et al. 
(I980j and Glassman (1980) have been reported in which whole plasma 
containing a depressant substance was bioassayed in vitro without 
antifoaming substances and with adequate oxygenation. 
A series of experiments were conducted to determine whether an 
endogenous myocardial depressant substance could be detected in the 
plasma of shock animals. The specific objectives were as follows. 
First, dogs were subjected to hemorrhagic shock conditions which, 
according to reports in the literature, should have been adequate to 
cause the formation of a depressant. Second, various physiological 
parameters were recorded during the hemorrhagic shock experiments to 
define the shock condition. Finally, the presence of a depressant in 
shock plasma was determined by immediately comparing shock plasma witn 
control plasma and a modified Krebs-Henseleit solution in a bioassay 
system utilizing isolated canine papillary muscle. 
Methods; Hemorrhagic Shock Experiments 
Methods of hemorrhage 
Seven adult dogs weighing 20.5 ^  4.1 (S.D.) kg were subjected to a 
hemorrhagic shock procedure based on the model of Wiggers (19150). Food 
was withheld from each dog at least fifteen hours prior to the 
experiment. A light plane of anesthesia was induced with intravenous 
sodium pentobarbital at an initial dose not exceeding 25 mg/kg. An 
endotracheal tube was immediately inserted and an electrocardiogram 
(Lead II) recorded. Arterial blood pressure and arterial blood samples 
were obtained via a polyethylene cannula (Clay Adams PE 205) which was 
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connected to a Statham P23 transducer and then inserted into the femoral 
artery and advanced near the heart. A second polyethylene cannula was 
inserted into the right jugular vein and advanced either into.the right 
atrium or in close proximity to the atrium, as determined at postmortem 
examination. Central venous pressure was then monitored with a water 
manometer. The left carotid artery was cannulated with a large bore 
(2.5 mm i.d.) cannula for infusion and withdrawal of blood (hemorrhage). 
This cannula was connected to a closed two liter siliconized Plexiglas 
reservoir to which 1000 units of heparin had been added. Flow into and 
out of the reservoir was regulated by varying the pressure in the 
reservoir with a hand pump and valve. The reservoir was maintained at 
57 C by a water bath. Calibration marks on the reservoir were used for 
periodically determining the shed blood volume. Recordings of the 
arterial blood pressure, mean arterial blood pressure, respiratory rate, 
and electrocardiogram were made on a Beckman Model R611 polygraph. 
Rectal temperature was continuously monitored with a YSI Model 47 
thermometer. Body temperature was maintained with a heating plate 
placed beneath the dog. Heparin sodium (500 U/kg) was administered 
intravenously immediately after all preparatory work was completed and 
at least 20-30 minutes prior to hemorrhage. A schematic of the 
preparation is shown in Figure 1. 
Some of the dogs were maintained on a Bird Mark VII respirator used 
in an assist mode either periodically during the procedure or throughout 
the experiment. All dogs were ventilated with either compressed air or 
room air. Oxygen consumption was determined in the remaining dogs 
concurrently assisted by the respirator. However, the method employed 
Blood Reservoir 
4 t 
ECG 
Hemorrhage: 
wi thdrawdl 
infusion 
Blood Presssure 
Carotid A. Femoral A. 
Blood Sample 
Intubation: 
Og consumption 
Respiratory 
rate 
Trachea 
Rectal Temperature 
Central Venou 
Pressure 
Blood sample Anesthesia: pentobarbital (25 mg/kg BW) Jugular v. 
Figure i. Schematic of the experimental preparation: hemorrhagic shock experiment 
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for simultaneously measuring oxygen consumption during assisted 
ventilation was later determined to be invalid. 
Hemorrhage was induced by opening the carotid cannula and allowing 
the blood pressure to equilibrate with the reservoir pressure which was 
maintained at 40 mm Hg. Shed blood volume was determined from the 
calibration marks on the reservoir and recorded. The dog was maintained 
in the hypotensive state until 40% of the maximum shed blood volume had 
been taken back up by the animal. All remaining shed blood was then 
reinfused over a 15-20 minute period by increasing the pressure in the 
reservoir. The dog was then monitored until such time as his mean 
arterial blood pressure declined to less than 60 mm Hg. A pressure 
decline to less than 60 mm Hg. MABP is generally considered to be 
indicative of irreversible shock. Exsanguination was rapidly 
accomplished by bleeding from the carotid cannula into the reservoir and 
via removal by syringe from the femoral artery. 
A gross postmortem examination was then performed to identify any 
overt pathological conditions, the placement of the cannulas, and the 
general appearance of the major organs of the chest and abdomen. 
The initial 200-500 ml of shed blood withdrawn during the 
hypotensive period were removed from the reservoir system, centrifugal 
at 2000 X G for 20 minutes at 4 C, and the plasma removed. This plasma 
was either used for bioassay (Control plasma) on a papillary muscle or 
processed as described later. The cellular fraction was then 
resuspended in a volume of saline equivalent to the plasma removed and 
returned to the reservoir. Plasma obtained at the final exsanguination 
(Shock plasma) was immediately iced and also prepared for bioassay or 
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further processing. 
Physiological measurements were made and samples obtained during 
five sample periods during the shock procedure. These periods are 
defined as follows: 
Period I = prior to hemorrhage but at least 20 
minutes after all preparatory work was 
completed; 
Period II = '30 minutes after reaching a stable 
mean arterial blood pressure (MABP) of 
40 mm Hg following the initial hemorrhage; 
Period III = not more than 30 minutes prior to 
reinfusion of all remaining shed blood; 
Period IV = 30 minutes after reinfusion of all shed blood 
Period V = just prior to exsanguination when the 
MABP was 60 mm Hg or at a higher 
pressure where the decline in MABP was 
so rapid as to prohibit sampling 
without risk of the dog prematurely 
dying. 
During each sample period, rapid tracings (25 mm/sec) were made on the 
polygraph, blood samples were taken from the arterial and venous 
cannulae, central venous pressure was recorded, and oxygen consumption 
was measured. 
Parameters monitored were arterial blood pressure; central venous 
pressure; electrocardiogram Lead II (ECG); respiratory rate; rectal 
temperature; oxygen consumption (limited); red and white blood counts; 
u 
plasma protein concentration and osmolarity; hemoglobin; packed cell 
volume; and plasma sodium, potassium, and calcium concentrations. 
Arterial and venous samples were also analyzed for pH, pCOg, PO2, HCO.^, 
total COg' and base excess/deficit. 
Analysis of Samples 
Arterial and venous blood samples were collected in heparin!zed 
syringes or Vacutainers during each sampling period and assayed as 
follows. Plasma protein was determined with an American Optical hand 
refractometer. Hemoglobin was measured by the cyanomethemoglobin method 
on a Beckman Spectronic 20 spectrophotometer. A Coulter Counter Model 
I14-30 was used to determine the red and white blood cell counts. 
Anaerobic blood samples were immediately iced and the blood gas 
parameters measured with an International Laboratories Model 513 Blood 
Gas Analyzer within fifteen minutes of withdrawal. Osmolarity of all 
samples was measured at the conclusion of the experiment with an 
Advanced Osmometer. Plasma samples were also analyzed for sodium, 
potassium, and calcium by several methods. Samples were refrigerated 
overnight and forwarded to the Veterinary Medicine Clinical Pathology 
Laboratory for analysis with an International Laboratories Model 345 
flame photometer the next day. Aliquots of plasma were also frozen and 
later assayed for sodium and potassium with a Technicon Autoanalyzer, as 
per Technicon Method File N-20B. Calcium concentration was also 
determined the same day of the experiment by the method described by 
Annino and Giese (1976). 
1!? 
Processing of plasma 
Both control and shock plasma were processed alike. Measured 
volumes of plasma were iced immediately upon withdrawal from the 
animals. All samples were subsequently kept at 4 C except during 
transfer and bioassay. Those samples for bioassay were analyzed for 
osmolurity and calcium concentration and adjusted with 0.1 N KCl or 0.' 
Ha OH to a pH of 7.4 before bioassay. All remaining volumes of each 
plasma were measured and the samples lyophilized for approximately 19 
hours (Labconco Freeze Dryer 5). The ratio of dried weight of the 
sample per original volume of plasma was used as the reconstitution 
factor. Therefore, in all subsequent experiments, material in 
equivalent volumes of original material could be compared. Drieu 
material was placed in a desiccator, containing desiccant, wnicn was 
then sealed under a vacuum and stored at -10 C until used. Appropriate 
samples could be removed and the remaining material returned to the 
freezer for storage. 
Results of the Shock Experiments 
The shock experiments were performed in order to obtain control and 
shock plasma for subsequent in vitro bioassay and to document the 
physiological status of the experimental animals during the procedures. 
All animals utilized in this study appeared healthy prior to 
experimentation. Further, no conditions were found at post mortem 
examination which would subject the results to question. Data, unless 
otherwise stated, have been expressed as mean _+ standard deviation of 
the mean (mean S.D. ). 
Characteristics of the dogs and the respective sample periods have 
Table 1. Summary of data on dogs and sample periods 
Seven dogs 
Body weight; 20.1 +_ 4.2 kg 
Calculated blood volume: 1,704 325 ml 
Percent of blood volume shed: 55.5 11. 
Time to respective sample period (minutes): 
Period I 0 (minutes) 
Hemorrhage 9*'3 ^  5. j 
Period II 52.7 + 10.6 
Period III 222.7 + 68.7 
Period IV 293.7 + 76.8 
Period V 564.3 + 112.8 
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been summarized in Table 1. The seven dogs, four males (one neutered) 
and three females, had a mean weight of 20.1 +_ 4.2 kg. Blood volume, 
estimated as of the body weight, equaled 1 ,704 2. )26 ml. 
Individual blood volumes calculated for each dog were used to determine 
the maximum percent total blood volume shed during the experiment. The 
maximum percent shed blood volume averaged 65.5 2 1 1.jib of the 
calculated total blood volume. Maximum blood volume loss was 5.7 _+ 1.1/6 
of the body weight. It required approximately 40-45 minutes to obtain 
the experimental objective of 40 mm Hg mean arterial blood pressure 
(MBP). Reuptake of 40^ of the shed blood volume occurred over an 
average of 170 minutes. The post-reinfusion and terminal state 
measurements were at subsequent average intervals of 71 minutes. 
Results of the hemorrhagic shock experiments have been summarized 
in Tables 2 and 5« The hemorrhagic period was defined by the reduction 
of MABP to levels consistent with the production of shock. Throughout 
the hemorrhagic period, MABP was maintained at the 40 mm Hg experimental 
objective. MABP increased to 88 +_ 25.1 mm Hg following reinfusion. 
Restoration of blood volume failed to restore MABP to the preshock level 
and is indicative of the physiological changes, such as pooling in 
vascular beds, transudation of fluids, and loss of autonomic tone, which 
are known to occur following prolonged and severe hypotension. There 
was a progressive decline in MABP during the post hemorrhagic 
observation period to 43«7 2, 15.1 mm Hg. This pattern is consistent 
with a loss of compensatory reflexes widely reported in a terminal state 
of shock in dogs. 
MABP was the controlled variable during the hemorrhagic period. It 
Table 2. Results of the Jiemori'hagic shock experiments 
Sample period 
Parameter I 1 1  III IV V 
Number (ri) 7 7 7 7 7 
Systolic blood pressure 
(mm Hg) 
159.2^'^ 
+_ 24.8 
60.0 
i 9.7 
6 0 . 0  
2 12.1 
1 1 5 . 0 " =  
^  2 3 . 6  
66.7 
2 21.3 
Diastolic blood pressure 
(mm Hg) 
119.9^ 
2 15.3 
31 .4 
+ 6.5 
28.4 
2 3.7 
7 6 .9° 
24.7 
33.4 
+ _  1 4 . 6  
Mean arterial blood 
pressure (mm Hg) 
133.6^ 
15.7 
41.0 
+ 6.0 
38. 1 
+^4.5 
88.7° 
_ +  23. 1  
43.7 
1 5 . 1  
Pulse pressure 
(mm Hg) 
39-4^ 
2 15.9 
26.9° 
+_ 10.0 
3 1.2^'° 
2 1 2 . 0  
38.1^ 
_+ 8.8 
33.2b 
+ _  1 0 . 8  
Central venous pressure 
(mm Hg) 
1  .2^ 
4.1 
- 1 . 9  
+_ 2.4 
- 2.3 
1 1.9 
-  1  .5 
+_ 1 .2 
- 1 . 2  
+_ 1 .8 
Heart rate 
(beats/minute) 
133.b^ 
_+ 24.2 
139.3^'° 
1 36.7 
1  7 6 .3° 
1 32.9 
151 .9^'° 
^ 41 . D  
153.0^ 
1 58.4 
Respiratory rate 
(breaths/minute) 
14.5 
2 9.0 
27.1 
+ 9.4 
20.4 
5.4 
1 9.7 
1 V.5 
2 2 .3"^  
1 9.5 
Packed cell volume 
(%) 
40.7^ 
+ 4.5 
49.2° 
+ 5.1 
56.3 
+ 4.7 
5 6 . 2  
^ G. y 
5 6  . 8  
1 5.0 
Red blood, count 5. 7^ 6.6 7.7 a, 1  8.'j 
(cells/mm^) 0.9 + 0.8 +^0.9 + 1.0 +  1 . 0  
Hemoglobin concentration 13.2 1b.4 17.9 17.7 17.5^^ 
(g/100 ml) + 1.8 1 + 2.4 1 2.4 
Mean corpuscular volume 71 .8 74. o 7j. 6 70.1 70.6^^ 
(microns ) + 6.7 +_ 6.7 +_ 6.2 2 11. t> 
Mean corpuscular 23. j 23.!; 23.5) 22.2 22.4 
hemoglobin (yyg) 2 2.0 + 2. b i 2.4 3.4 2 4.9 
Mean corpuscular hemo­ j1 .6 31 .8 31.8 30.8 
globin concentration 1 2.1 j.6 2 2.0 2 5.1 +_ 2.8 
Plasma protein conc. 6.2 5.3^ 6.1 6.3 5.9 
(g/100 ml) 2, 0.7 + 0.6 4^ 1 .0 + 1 .0 +_ 1 .0 
Plasma osmolarity 299.7^ 322.7^'® 318. '^313.4° 
(mOsm/k^) 1 V. 1 +_ 9.2 1 14.7 i 12.2 + 6 . 3  
^ All values expressed as moan S.D. 
b,c,e,f [vjgfji^g with the same letter or no letter are not statistically 
different; t-test for significance; (p<0-05). This method for expression of 
statistical significance is different from that used in all other tables. 
^ Wumber (n) = 5. 
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Table 5. Results of the hemorrhagic shock experiments: pH and 
blood gas parameters 
Period Period Period Period Period 
Parameter I II III IV V 
pHa 7 - 4 2 8 ^ ' ^  7. 7.091^^ 7 . 1 3 1 ' ^ ' ' ^  7.263°' 
+ U.076 + _  0 . 1 0 3  1  0 . 1 7 9  0.247 + _  0 . 1 9 2  
PaC02 33.0^ 1 9 . a  19.9 20.4 19.5 
(mm Hg) +  5 . 8  2 .  4 . 4  +  1 6 . 1  1 9 . 2  8 . 6  
HCO2 2 1 . 1  11.j 6 . 1  6 . 9  9.5 
(meq/l) 1 2-1 _ +  4 . 0  +  6 . 7  1 5-2 1 7 . 3  
Base excess/ - 1  . 7 ^  -11. 2 °  -2j. - 2 0 . 5 ^ ^ ' ®  - 1 6 . 5 ®  
deficit (meq/l) +  2 . 7  +  5 . 6  4 ^  1 0 . 5  + _  8 . 4  + _  6 . 3  
Pa02 1 0 8 . 1 ^  109.1^ 125.3° 119.8^'° 114.1' 
(mm Hg) 1  i y . 3  2 5 . 0  ^ 1 6 . 7  1  1 4 . 3  16.9 
Pv02 44.6^ 20.2° 55.2^ 4 2 . 8 ^ ' ' ^  30.1' 
(mm Hg) i 5 . 2  + ^ 9 . 8  1 16.9 +  1 6 . 0  1  4 . 2  
A-V O2 3 . 6 ^  14.5° 8 . 0 ^  10.6°'^ 12.4' 
difference i  1  - 5  1 5 . 1  +  3 . 0  +  5 . 1  +  4 . 0  
(ml/ 1 0 0  ml) 
Number (n) 7  7  7  7  7  
All values expressed as mean S.D. 
Means with different letters are significantly different; 
t-test for significance; (p<0.05). 
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was arithmetically derived from the respective systolic and diastolic 
blood pressures (MABP = diastolic pressure + 1/j the systolic-diastolic 
pressure difference). Pressures of less than 60 mm Hg, such as observed 
during the hemorrhagic period, would be expected to compromise perfusion 
of most of the organ tissues of the body. Pressuiy was restored to an 
average of 11$+^ Z'j.o systolic and 76.y +_ 24.7 mm Hg diastolic upon 
reinfusion. However, pressure alone would be no guarantee of local 
blood flow. Pulse pressure was altered significantly only durin,] the 
early hemorrhage when blood was initially lost and stroke volume 
reduced. Compensatory responses to restore blood volume, such as fluid 
shifts and intense vascular constriction no doubt contributed to the 
normalization of pulse pressure. Central venous pressure (CVP) declined 
significantly with the loss of circulating blood volume and never 
returned to control levels. 
Hypotension characteristically produces reflex sympathetic 
stimulation. Although heart rate did tend to increase over time in 
hemorrhage, no significant changes were noted throughout the experiment. 
Lack of a more pronounced increase in heart rate could have been caused 
by early depression of the medullary centers or a relatively high 
initial sympathetic output produced by a vagolytic action of 
pentobarbital. Additional explanations for the failure to observe a 
more marked increase in heart rate may be either loss of the sympathetic 
limb of the baroreceptor response with a predominance of the vagal tone, 
as observed by Glaviano and Klouda (1965); an acidosis induced depressed 
myocardial responsiveness to catecholamines, which has been reported by 
Darby et al. (1950), Ford et al. (1958), Thrower et al. (1961), and 
Wild enthai et al. (1968); or the predominant reflex effect of the 
stimulated peripheral chemoreceptors on vasomotor activity without a 
major sympathetic effect on the heart, as reported by Doraing et al. 
(1952) and Downing and Siegel (1965). Respiratory rate was almost 
doubled in early shock but declined to a level about 35^ above control 
during the duration of the experiments. This may also reflect medullary 
depression or a decreased respiratory drive concurrent with the 
reduction in arterial PaCOg. 
Many reflexes are normally invoked following hemorrhage. Pressure 
is primarily restored via sympathetic alteration of vascular capacitance 
and the intense vasoconstriction due to angiotensin. Volume, however, 
is restored both by renal mechanisms mediated by aldosterone and 
antidiuretic hormone and by the translocation of fluid into the vascular 
compartment as hydrostatic pressure is reduced. Fluid movement appears 
to be reflected in the significant decrease in plasma protein during 
early hemorrhage. Oxygen carrying capacity may have been partially 
restored by contraction of the spleen and other reservoirs for red blood 
cells in the dog. This could explain the increase in the red blood cell 
count and packed cell volume in early hemorrhage. The hemorrhaged blood 
entered and left the reservoir at the bottom which may explain why there 
was a marked increase in the red blood cell count or hemoconeentrâtion 
during the duration of the experiment despite the apparent dilution of 
plasma proteins. Blood was reinfused over the course of the liemorrhage 
that was becoming more packed with red blood cells as they settled. 
Hemoglobin concentration paralleled the changes in red blood cell count 
and packed cell volume. Throughout the experiment, no differences were 
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noted in either the size or hemoglobin content of an individual cell as 
evidenced by the values for MCV, MCHC, and HCH. 
Oxygen content of the arterial and venous samples was determined 
from the respective values for hemoglobin concentration, PaO^, pH, and 
base excess/deficit. Corrections were made for base excess/deficit, 
temperature, and pH, as described by Altman and Dittmer (1974)- The 
amount of oxygen extracted from the systemic circulation or the 
arterial-venous (A-V) oxygen content difference was calculated and is 
shown in Table 3. Extraction increased dramatically during the early 
hemorrhage. Less oxygen was extracted later in the hemorrhagic period. 
This may reflect increased shunting which is typical in severe and 
prolonged hypotension. Extraction of oxygen increased upon reinfusion 
of all shed blood, but only the final measurement was significantly 
greater than that observed in Period III. Oxygen extraction is 
dependent on flow to tissues, tissue utilization itself, and physical 
factors, like pH, which favor unloading from the hemoglobin. 
Restoration of blood volume should have improved perfusion to many of 
the tissue beds. Therefore, perfusion, utilization, and acidity 
probably all account for the increased extraction. A pronounced oxygen 
debt which should have accrued during the hypotension would also need to 
be paid. 
Hemorrhage and a progressive state of shock are almost always 
accompanied by acid-base changes. A progressive metabolic acidosis was 
observed during the hemorrhage. Accumulation of fixed or nonvolatile 
acid in early hemorrhage, as indicated by a base deficit of -11.2 +_ 2.1 
meq/l, became more exaggerated in late hemorrhage and reached -23.3 2. 
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4.0 meq/l. This would be predicted with a compromised blood flow and 
loss of the renal route of excretion during the hypotensive period. 
Respiratory compensation is suggested by the increase in respiratory 
rate and concomitant reduction in PaCO^. The respiratory rate did not 
increase to levels which might be expected under the conditions 
described. This may indicate a central depression of respiratory drive. 
Any compensation was inadequate to prevent a further reduction in pH 
from 7.365 0.103 early in hemorrhage to 7.091 ^ 0.179 during Period 
IV. 
The physiological status of the dogs was not restored to the 
initial control status following the reinfusion of all shed blood. It 
appears that there were significant alterations produced by the 
hemorrhagic period. Mean arterial blood pressure increased to only 68.7 
+_ 23.1 mm Hg upon restoration of the blood volume. Central venous 
pressure also tended to increase. Heart rate was reflexly decreased, 
while respiration remained unchanged. Although the packed cell volume, 
hemoglobin concentraton, and the RBC count did not significantly 
increase, the RBC count did progressively increase from 7.7 0.4 in 
late hemorrhage to 8.5 0.7 million/mm^. Neither plasma protein 
concentration, osmolality, arterial PaCO^, nor PaO^ were altered. The 
acidosis was partially corrected to 7.131 2. 0.247, perhaps due to 
restoration of the blood buffers and restoration of filtration pressure 
in the kidneys. 
The only significant difference observed between the terminal and 
post-reinfusion periods was the decrease in arterial blood pressure. 
This decrease was exponential in about half of the dogs and necessitated 
taking early measurements. Regardless of the timing of the samples, the 
MABP was 45.7 15*1 mm Hg prior to exsanguination. Central venous 
pressure was significantly higher only during the control period and no 
difference was observed between the other periods. The CVP 
progressively declined to a minimum in late hemorrhage, but then tended 
to increase in the remainder of the experiments. Increased CVP may 
suggest a central cardiac impairment. 
Some impairment of myocardial function seems apparent from the 
data. The terminal heart rate, concurrent with a progressive 
hypotension, did not differ from the post-infusion period where blood 
pressure was partly restored. Marked elevation or depression of the 3-T 
segments in the electrocardiogram was consistently noted as early as 
Period III in a majority of the dogs. These alterations were more 
pronounced and observed in all dogs in the terminal stages. Ectopic 
foci were especially frequent during the terminal period. The tendency 
for CVP to increase late in the experiment, although not significant, is 
also suggestive of central cardiac failure. Myocardial depression would 
certainly be expected with the acidity, reduced myocardial perfusion 
pressure, and ischemia which are typical of a shock state. 
None of the blood parameters were significantly altered in the 
terminal period. The RBC count tended to increase which may have been 
due to either a further increase in circulating cells or a loss of 
vascular fluid. No change in the ratio of cell numbers per fluid volume 
occurred, however, as evidenced by the constant PCV over the last three 
periods. Oxygenation of blood did not appear to have been impaired 
throughout the experiment, as the PaO^ was consistently in excess of 100 
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mm Hg. 
Discussion 
Physiological response to shock in vivo involves a complex 
interaction of many variables acting independently, simultaneously and 
either cooperatively or antagonistically to one another. Examination of 
these responses is difficult, at least, in the intact dog and would 
require equipment and methods beyond the scope of this study. These 
experiments were conducted to obtain plasma from dogs in a progressive 
irreversible stage of shock. The data collected are consistent with the 
patterns reported by Wiggers (1950, 1956), Crowe11 and Guyton, Rothe and 
Selkurt (1964), and Bond et al. (1977). Those studies were specifically 
designed to examine hemorrhagic shock. 
It is possible to only speculate whether central cardiac failure 
was a factor in the loss of compensatory function without a measurement 
of cardiac output. However, severe metabolic acidosis, the S-T segment 
alterations in the electrocardiogram which are indicative of myocardial 
ischemia, and the observed arrythmias late in the experiments are 
presumptive evidence of some cardiac impairment. Normal canine cardiac 
function has been shown to be relatively resistant to severe lactic 
acidosis by Linden and Norman (1969), Downing et al. (1969) and Rocamore 
and Downing (1969). An effect of acidosis on left ventricular function 
has been observed by Downing et al. (1966a, 1966b, 1969) when either 
hypoxia or adrenergic failure was present, but generally not until the 
acidosis reached a pH of 6.8 - 7.0. A comparable pH in late hemorrhage 
and an apparently unresponsive heart were observed in this study. Ng 
et al. (1967), Linden and Norman (1969), and Downing et al. (1971 ) have 
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reported that acidosis potentiates vagal slowing of the heart and this 
may partially explain the lower heart rates late in the experiments. 
Downing and Siegel (1963) have observed that severe hypotension causes 
accumulation of metabolites and hypoxia in the peripheral tissues which 
contributes to a reflex sympathetic vasomotor response but not 
necessarily increased discharge to the heart. Further, dogs in 
prolonged hypotension experience a loss of baroreceptor control due to 
diminished responsiveness of the sympathetic efferents, as reported by 
Glaviano and Klouda (1965)« Loss of blood volume will cause a decrease 
in the cardiac output and systemic arterial pressure which then elicits 
an increase in peripheral resistance. Severe hemorrhage, as induced in 
these experiments, is followed over time by a progressive failure of the 
animals to maintain systemic arterial pressure. Reuptake of blood 
concurrent with the maintenance of pressure (at MABP of 40 mm Hg) can 
only occur if more vascular fluid is lost or the relative blood capacity 
of the animal increases. A net fluid loss would be consistent with the 
hemoconcentration observed, but the stable plasma protein concentration 
throughout most of the recording periods is more consistent with 
increased erythrocyte mobilization and release rather than concentration 
via fluid loss. 
Considerable evidence from the literature has been cited which 
supports the failure of peripheral circulation as the primary mechanism 
for the circulating decompensation in progressive shock. Reduced 
perfusion pressure and increased sympathetic tone to the peripheral 
tissues contribute to the accumulation of metabolic products, acid, and 
hypoxia in those local tissues. Blood flow to a vascular bed is 
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determined by the net effect of autoregulation of blood flow and the 
autonomic innervation of that bed. Autoregulation of various tissues 
beds is independent of the autonomic response and tends to restore local 
perfusion while the autonomics decrease capacitance in order to preserve 
blood' flow to the brain and heart. The amount of local flow varies with 
the specific vascular beds within a species. Skeletal muscle 
vasculature is very responsive to local metabolic products and is well 
dilated due to autoregulation in shock. This increase in the vascular 
capacity is thought to be the initiating factor in decompensation, as 
suggested by Bond et al. (1977). Reuptake of the shed blood during the 
hemorrhagic period would be partly in response to a normal physiological 
mechanism. Body temperature was maintained with supplemental heat in 
the present experiment. Therefore, a normal temperature for metabolic 
activity in skeletal muscle would have been maintained during a phase of 
shock when temperature normally would fall due to peripheral 
constriction. Increased metabolic byproducts in hyperthermia have been 
shown by Wiggers (1950) to contribute to a more rapid reuptake of shed 
blood and subsequent irreversible collapse of the animals. 
Bond et al. (1976), Bond et al. (1977), Lefer (1975), Kobbold and 
Thai (1953), Rothe and Selkurt (1964), and Selkurt (1970) have all 
reported that peripheral circulation may also fail due to the release of 
vasodepressor or humoral substances. Altered vascular responsiveness to 
circulating catecholamines, as reported by Bond et al. (1979), may also 
contribute to peripheral collapse• It is the release of humoral 
factors, like the myocardial depressant factor (MDF) described by Brand 
and Lefer (1966), that is most pertinent to the subsequent section of 
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this study. The pancreatic blood flow is especially compromised in 
severe hypotension, as shown Bor et al. (1980). Pancreatic 
hypoperfusion has been shown by Ferguson et al. (1972) to be a causative 
factor in the production and release of HDF. 
Methods: Bioassay of the Shock Plasma 
Preparation of papillary muscle 
Puppies weighing 1.5-3-5 kg were anesthetized with intravenous 
sodium pentobarbital (approximately 25 mg/kg). When a satisfactory 
level of anesthesia was obtained, the chest was opened and the heart 
rapidly excised and immediately placed in a modified Krebs-Henseleit 
solution. The heart was then transferred to a second container of 
Krebs-Henseleit solution (21 C) which was gassed with 100% oxygen. 
The chambers of the right side of the heart were opened by making 
incisions along the lateral margins of the free walls and a papillary 
muscle was then selected. Criteria for a good papillary muscle were 
length, cross-sectional area, and shape. Although Pinto (1980) has 
suggested that the ideal muscle should be greater than 10 mm in length 
and not over 1 mm in diameter, those dimensions are rare in puppies. A 
typical puppy muscle is 4-6 ram long and usually triangular in shape. 
Often the muscle is not distinct, but a composite of adjacent muscles 
fused at the base. Therefore, it was sometimes necessary to split 
muscles to obtain an acceptable cross-sectional area. This was 
accomplished with a #11 scalpel blade inserted between branches of the 
chordae tendineae of a carefully stretched muscle. 
Once the muscle had been selected, a stainless steel hooking device 
attached to one end of a silver chain was placed around the chordae 
Muscle snare Gas in 
Muscle 
•Muscle clamp 
jMuscle 
Fluid 
out Fluid 
in 
Muscle 
Chamber 
Electrode 
Figure 2. Schematic of the mounting apparatus for the papillary muscle 
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tendineae and secured, as shown in Figure 2. The chordae tendineae and 
a small piece of valve were then cut free from the tricuspid valve. A 
2-3 nun segment of ventricular wall at the base of the papillary muscle 
was dissected and the muscle was excised. The base segment was then 
inserted and clamped in a muscle holder. Care was taken to avoid over 
stretching the muscle. Muscle, chain, and holder were then transferred 
into the muscle chamber. The elapsed time from cardiectomy to transfer 
was less than seven minutes and averaged about 4-6 minutes. Refer to 
the section Description of bioassay apparatus for details of the 
bioassay system. 
Equilibration of the muscle 
A preload weight was initially selected for each muscle based on 
subjective assessment of length and cross-sectional area. This was 
usually 0.4 0.2 g. The preload weight was often increased during the 
first minutes to carefully stretch the muscle and improve oxygenation 
and performance. An initial stimulus of 100 volts, 5 msec duration, and 
50 hertz was applied. The voltage was decreased to 40 volts as soon as 
the muscle began contracting and following the stimulus. Frequency of 
stimulation was slowly decreased to 12 hertz over several minutes once 
the muscle ceased contracting on its own and completely followed the 
stimulus. It typically required 1-3 hours at 27 C to equilibrate the 
muscle. A muscle was deemed equilibrated when no change in isotonic 
shortening or velocity was observed over 15 minutes. The preload was 
periodically adjusted up or down during the equilibration procedure 
towards a maximum isotonic shortening. 
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Determination of preload 
Each muscle was initially equilibrated with a preload weight 
estimated to be near Lmax. Lmax is the muscle length caused by that 
weight which when added to the lever will cause a sarcomere alignment 
which produces a maximum degree of isotonic shortening. A series of 
known preload weights which usually ranged from 0.04 to 2.0 g were added 
to the isotonic lever. Sufficient weight, based on a subjective 
evaluation, was added to the lever and caused stretching of the muscle 
beyond Lmax, but not in excess so as to damage the muscle. The preload 
weight was then sequentially decreased as follows. A weight was hung on 
the lever and the muscle equilibrated for 6-10 contractions (uniform 
number per given experiment) and then exchanged for a lighter weight. 
At least 10-12 weights were ordinarily tested with a minimum of three 
weights stretching the muscle in excess of Lmax. Isotonic contractions 
were recorded on the polygraph. Recorded amplitudes of the isotonic 
contractions for each weight were then measured. These data were then 
fitted (least squares method) to the following formula with a computer. 
Lmax was determined as the intersection of the ascending and descending 
limbs of the preload curve as described by the following equations. 
EQUATION #1 
Ascending limb: y = a + b (in x) 
EQUATION #2 
Descending limb: y = a (e)^^ 
The values a and b are estimates of the intercepts and slopes obtained 
by the fit while e is an irrational number whose value is approximately 
2.71828. Each muscle was then adjusted to 90^ of Lmax with the 
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appropriate weight and further equilibrated a minimum of 30 minutes. 
Testing of solutions 
The respective test solution (either Krebs-Henseleit or plasma) was 
added to the muscle chamber and equilibrated 30 minutes before measuring 
responses to various afterloads. Modification of the system for use 
with plasma is described in the section Description of bicassay system. 
Krebs-Henseleit solution was always tested first and last for several 
reasons. Krebs-Henseleit solution functioned as a standard reference 
throughout this entire study. Changes in the function of isolated 
tissue with time are normally expected and must be considered in 
assessing the effects of the various test materials. Such changes can 
be minimized by proper mounting technique, small cross-sectional area, 
and maintenance of pH and oxygenation. Further any irreversible effects 
of the depressant materials on muscle must be differentiated from those 
changes with time. Periodic measurements with the Krebs-Henseleit 
solution over the 5-8 hour experiment gave a relative indication of time 
changes which could be contrasted to changes occurring in the relatively 
short time span for testing other material or agents. Data obtained 
during the last treatment with the Krebs-Henseleit solution were used 
for all comparisons to both control and shock plasma. It should be 
recognized that this tends to negate changes with time but also tends to 
underestimate any depression caused by the plasma or other intervention. 
Afterloading of muscle 
Muscle response to each test solution was evaluated after 
equilibration by measuring the contractile response to a series of known 
afterloads. Refer to the section Description of bioassay equipment 
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for complete details on the operation of the equipment. The basic 
procedure was as follows. Preload weight was maintained on the isotonic 
lever and kept the muscle at 90% Lmax. A bar attached to the hydraulic 
cylinder of a microdrive unit (David Kopf Instrument Inc.) could then be 
lowered to the lever removing some of the preload weight and cause 
shortening of the muscle. Known weights (afterload) were added and the 
bar repositioned so as to reestablish the sarcomere alignment at 905b 
Lmax as determined by the polygraph recording. After approximately 
eight contractions, two successive contractile cycles were recorded at 
25 mm/sec on the polygraph. The afterload was then removed, the bar 
completely withdrawn from the lever, and the muscle allowed to 
equilibrate approximately eight contractions before the next afterload. 
The initial priority was to locate the maximum load (Po) which just 
prevented isotonic shortening. All subsequent afterloads tested were of 
a decreasing magnitude. Number of weights tested ranged from about 
10-20. It usually took 20-50 minutes to complete an afterload curve. 
The response to the preload weight was recorded at the beginning and end 
of the test and was used as an indication of changes with time and 
irreversible changes due to the shock or control plasma over the test 
interval. The smallest afterload weights were generally 0.12, 0.08, and 
0.04 g, respectively. It is known that the relationship between load 
and the other measured parameters is relatively linear over the middle 
range of afterload weights between preload and Po. Therefore, more data 
were collected at the extremes where changes are less linear. 
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Measured parameters and calculations 
Measurements made from the recordings are shown schematically in 
Figure 2 and are defined as follows. 
1.) Load (P) = known afterload weight. 
2.) Maximum velocity of contraction (Vc) : calculated from the 
maximum angle drawn as a tangent to the contractile phase of the 
isotonic contraction (9c). 
EQUATION k'i 
Vc = (tan 9c) x (calibration factor in mm/mm) x 
(chart speed in mm/sec) 
3.) Maximum velocity of relaxation (Vr): calculated from the maximum 
angle drawn as a tangent to the relaxation phase of the isotonic 
contraction (er) 
EQUATION #4 
Vr = (tan 9r) x (calibration factor in mm/mm) x 
(chart speed in mm/sec) 
4.) Calibration factor: At the conclusion of each experiment the 
chain attached to the muscle was disconnected from the transducer 
lever and the lever displacement, calibrated in microns/millimeter of 
pen deflection, was recorded and converted to millimeter of isotonic 
shortening/ millimeter pen deflection. 
5.) Latency intervals: The intervals from stimulus artifact to 
various phases of the contractile cycle were measured on the 
recording with a micrometer and converted to time (distance in mm/ 
chart speed in mm/sec). 
TMVC = time to maximum velocity contraction or 
maximum rate of developed tension 
Differentiated 
signal 
dT/dt 
or 
dL/dt 
Isotonic 
shortening or 
active or developed 
tension (AT) 
Preload or 
resting tension (RT) 
Stimulus 
TMVR 
dT/dt +dT/dt/ 
LAT = time to onset of tension 
or contraction 
TPC = time to peak contraction 
TPT = time to peak tension 
TMVR = time to maximum velocity of 
relaxation or maximum decline 
in developed tension 
DUR = duration of contraction or 
tension 
Vc = maximum rate of shortening 
+dT/dt = maximum rate of tension 
developed (contraction) 
Vr = maximum rate of relaxation or 
lengthening 
-dT/dt = maximum rate of decline in 
tension (relaxation) 
Recordings were either of Isometric or isotonic contractions. 
Figure 3. Measured parameters In the papillary muscle bioassay 
51 
EQUATION #5 
Time = (distance in mm) / (chart speed in mm/sec) 
These intervals are defined as follows: 
Latency (LAT) = time from stimulus to onset of the contraction. 
Time to maximum velocity of contraction (TMVC) = time from stimulus 
to the peak of the differentiated signal. 
Time to peak of contraction (TPC) = time from stimulus to the peak 
of the isotonic contraction. 
Time to maximum velocity of relaxation (THVR) = time from stimulus 
to the negative peak of the differentiated signal. 
Duration of the contraction (DUR) = time from stimulus to the return 
of the isotonic contraction tracing to the baseline. 
Data were expressed per cross-sectional area where appropriate. All the 
afterload data for a given treatment were then fitted to a third order 
polynomial equation (least squares method). Normalization of data 
between muscles was accomplished by calculating from each polynomial 
equation the respective values for each parameter which corresponded to 
ten percent increments of Po. 
EQUATION #6 
2 3 y = c + ax + bx + cx 
Measurement of muscle length 
A catheotometer was used during the experiment to determine muscle 
length to the nearest 0.1 mm while the muscle was at 90^1 Lmax. The most 
difficult aspect of this measurement was assessing where muscle ended 
and chordae tendineae began. Visualization was optimized by focusing a 
light on the muscle. Multiple measurements were made and the values 
were generally very consistent. 
Measurement of cross-sectional area 
At the conclusion of all testing, the muscle holder, chain, and 
muscle were removed from the chamber. The muscle was transected as it 
entered the holder with a scalpel. A dissecting microscope was then 
used to visualize and cut the chordae tendineae from the opposite e;.d o 
the muscle. The muscle was then blotted and weighed on an analytical 
balance to the nearest 0.1 mg. This procedure was repeated several 
times and an average value used for subsequent calculations. Each 
measurement was made only after the muscle was resubmerged in 
Krebs-Henseleit solution. Cross-sectional area was determined by the 
following formula: 
EQUATION til 
XSA = (1.065 mg/mm^) x (weight of muscle in mg) 
(muscle length in ram) 
The value 1.065 mg/mm^ is an approximation of the muscle density 
reported by Park and Driscoll (1982) for canine myocardium. 
Description and construction of the bioassay system 
The bioassay system consisted of a muscle chamber/water bath, a 
mounting apparatus for positioning the papillary muscle in the muscle 
chamber and attaching the muscle to the recording system, a microdrive 
unit for altering and maintaining muscle length, a recording system, a; 
a peripheral system for circulating fluid in the muscle chamber and 
oxygenating plasma. 
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Mounting apparatus for papillary muscle The muscle clamp 
consisted of two Plexiglas plates connected by three stainless steel 
tubes, as shown schematically in Figure 5. Gas for oxygenation of the 
chamber fluid was passed through one tube while the other two functioned 
as ports for circulating the chamber fluid via a circulating pump. The 
top plate mounted to the top of the water bath/ muscle bath system and 
maintained the muscle clamp in a fixed position. The lower plate was 
divided into two sections. One was permanently attached to the 
stainless steel tubes while the second formed the actual clamp. It 
could slide over a pair of stainless steel tubes embedded in the other 
half of the plate. When the clamp was closed it would securely hold the 
wall end of the dissected papillary muscle. A stimulating electrode was 
embedded into the fixed half of the clamp in intimate contact with the 
muscle. A second electrode was mounted adjacent to the three stainless 
steel tubes and parallel to the muscle. 
A snare device was used to connect the other end of the muscle to 
the transducer. It was constructed from a stainless steel rod bent to 
form a snare, as illustrated in Figure 5- A small piece of stainless 
steel tubing was slipped down over the rod and was utilized to close and 
securely lock the snare around the chordae tendineae. The other end of 
the rod was attached to a silver chain which connected to the lever 
mounted on the transducer. 
The main gas tube was divided at the base and connected to three 25 
gauge tubes projecting from the clamp near the base of the muscle. This 
increased the oxygenation of the fluid by increasing the number of 
smaller gas bubbles and also should have contributed to mixing of the 
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chamber fluid. Oxygen tensions in the circulating fluid measured in 
excess of 500 mm Hg. One of the vertical tubes for circulating fluid 
was partially transected at a level near the top of the muscle bath. 
This enabled circulation of fluid from bottom to top of the chamber and 
also promoted good mixing of the fluid. 
Chamber system The double chambered system consisted of a 
muscle bath or chamber surrounded by a water bath for maintenance of 
constant temperature. This device is schematically presented in Figure 
4. The water bath or outer chamber was formed by sandwiching a Pyrex 
glass staining jar between two Plexiglas plates. A rubber gasket was 
placed between the plates and the glass and the chamber was sealed by a 
series of bolts which compressed the plates around the jar. Water was 
heated to maintain the bath temperature at '37 C and was circulated 
between a Haake constant temperature water bath and the outer chamber 
through ports installed in the top plate. Equilibration of the water 
bath, initially at room temperature, required no more than 30 minutes. 
Test solutions were prewarmed to 37 C prior to being exchanged. 
However, even solutions at room temperature would warm to 37 C within 
1-2 minutes when added to the testing chamber. Temperature in the water 
bath remained constant over the duration of any experiment. 
The muscle chamber itself consisted of a glass vial which was 
fitted beneath a hole in the center of the top plate and into a recessed 
area on the inner aspect of the plate. It was sealed to the top plate 
by compression created when a small Plexiglas plate positioned beneath 
the vial in the chamber was bolted to the top plate. Vials were 
periodically cleaned with acid and resiliconized. The chamber volume 
Gas in 
Chamber fluid—« 
out ^ 
- Chamber fluid 
in I From circulating 
••-water bath To circulating 
water bath •* 
l i C  
Muscle 
chamber 
Muscle clamp 
** Water Jacket 
Figure 4. Schematic diagram of the chamber system for bioassaying papillary muscle 
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was normally between 8-10 ml with the muscle clamp mounted. However, 
the same volume was always used on a given day when testing. This 
system was adequate to permit visualization of the muscles from the side 
for gross observation and measurement of muscle length with a 
catheotometer. The intact chamber system was mounted on a track system. 
It could be moved laterally by a ratchet device to align the muscle 'rfith 
the transducer and then securely locked to prohibit movement. 
Fluid was recirculated through the chamber by a pump located 
external to the chamber. Emptying the chamber could be accomplished by 
disconnecting the tubing connecting the chamber with the pump and 
pumping the fluid out. A combination pH probe was mounted into a "T" 
device inserted into the external fluid circuit. The combination of a 
flat bottom probe and the design of the device helped to minimize the 
volume of fluid in the "T" device. An Orion Research Model 601A digital 
pH meter was used to continuously monitor pH throughout each experiment. 
A hydraulic cylinder driven by a microdrive unit (David Kopf 
Instruments Inc.) with a rigid rod attached was positioned over the end 
of the isotonic muscle lever and was used as a stop to limit the 
movement of the isotonic muscle lever. Extension of the cylinder in 
micron units permitted very accurate positioning of the lever system. 
During an afterload measurement the lever could be lowered, causing 
shortening of the resting muscle length, and a selected afterload weight 
could then be added to the opposite end of the lever. The muscle could 
then be returned to the resting length at 90% Lmax by withdrawing the 
cylinder until the appropriate length, as determined by the polygraph 
recording, was reached. Known changes in the position of the muscle 
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lever caused by raising and lowering the cylinder were used to calibrate 
the polygraph recording for muscle length changes. 
Muscle shortening was measured with a isotonic muscle transducer 
(Gould Inc.) and recorded on a Beckman R-611 polygraph. Output of the 
channel recording change in muscle length was differentiated and the 
change in muscle length per time was recorded as a an indicator of 
velocity. The differentiator was designed and built by Dr. Wang Tang, 
Electrical Engineering Department, Iowa State University. Delivery of 
the electrical stimulus by a Grass SD9 stimulator to the muscle through 
silver electrodes was also monitored on the polygraph. Continuous 
recordings of all parameters were made throughout each experiment. 
Diffuser system A diffusion system was designed to maintain 
adequate oxygen tensions yet eliminate the foaming when whole plasma was 
added to the muscle chamber. Schematics of the system are shown in 
Figure 5• 
The chamber was constructed from two plates of Plexiglas (0.79 x 
5.81 X 45-4 cm). Specific measurements are given in the schematics. A 
groove was made on the central portion of one plate. The plates were 
then bolted together to form a sealed chamber. A series of seven 
stainless steel tubes were sealed in holes drilled into each end of the 
chamber. Seven lengths of a thin-walled silastic tubing (Ronsil 
sialatube, Ronsil Rubber Products, Division Rodhelm Reiss, Inc., Bell 
Head, ÎI.J.) with an I.D. of 0.889 mm, and a wall thickness of 0.254 mm 
were fitted into the groove and onto the tubing ends extending into the 
chamber. Tubes were placed in series by attaching a short length of 
polyvinyl tubing to the appropriate stainless steel tubes extending 
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38. 1 r.m 
Figure 5. Schematic diagram of the diffuser system for assaying plasma 
outside of the chamber. A single tube on either end functioned, 
respectively, as the inlet for gas (95% 0^, 5% CO^) and an outlet. The 
gas was saturated with water vapor prior to entering the chamber. Two 
additional stainless steel tubes were inserted into the chamber on each 
end of the chamber as inlet and outlet ports for the circulated fluid 
(plasma or K-H). Only one port on each end was normally used. The long 
continuous series of silastic tubing created a large surface area for 
optimum diffusion of oxygen out into the fluid circulated through the 
chamber around the silastic tubing. Fluid was circulated by either the 
circulating pump in the assay system or an auxiliary pump used only when 
the fluid was being equilibrated prior to connecting into the system. 
Approximately 1-5 ml of fluid was accommodated inside the chamber which 
created a surface area to volume ratio sufficient to maintain the PO in 
the fluid in excess of 500 mm Hg. 
Results and Discussion 
Muscle parameters and composition of the test solutions 
The characteristics of the papillary muscles used for bioassay and 
the concentration of selected electrolytes in the test solutions are 
summarized in Table 4. Although seven shock experiments were conducted, 
only four bioassays of the whole plasma harvested from those experiments 
could be completed. The remaining experiments could not be completed 
the same day because of either irreparable damage to the muscle without 
suitable replacement or failure to obtain muscles of sufficient quality 
from the available animals which were stable enough to conduct the 
tests. Any attempt to store plasma for later assay would have been 
unacceptable as the composition of the plasma may have been altered over 
time due to proteolysis, precipitation of proteins, or alterations in 
calcium concentration or osmolarity. Resolution of the presence of an 
endogenous depression may also have been obscured by the degradation of 
the molecule during storage. The muscles which were tested were some of 
the better quality muscles utilized throughout this entire project. At 
least 3-10 hours minimum were required to complete the assays which 
included approximately one hour for each solution. Despite the 
duration, there was only a ten percent difference between K-H1 and K-H2 
in maximum isotonic load (Po) and approximately twenty percent change in 
velocity of contraction over the time period from the beginning of 
testing to completion. There was a time lag of 0.5 - 1.5 hours between 
K-H1 and the next solution tested. 
There were significant differences in the composition of the test 
solutions, as shown in Table 4. Sodium concentration, however, was 
remarkably constant in all solutions and did not differ. Potassium is 
normally lost from the intracellular site when there is a loss of 
cellular integrity, as in shock. 
The potassium concentration in the shock plasma was significantly 
increased by 60? and 70% relative to the Krebs-Henseleit solution and 
control plasma. Two papillary muscles were used in pilot experiments to 
compare a Krebs-Henseleit solution containing 7.5 meq/l of potassium 
with the standard Krebs-Henseleit. No discernible effects on the same 
measured parameters were observed. 
A significantly lower calcium concentration was also measured in 
the shock plasma relative to both K-H and control. The reduction 
amounted to 13? and 15?, respectively. A linear relationship between 
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Table 4. Summary of muscle characteristics and composition 
of the tested solutions 
Muscle characteristics : 
Muscles: n = 4 
Length = 6.4;;J;_0.tjram^ 2 
Cross-sectional area = 1.41 + 0.45 mm 
Selected electrolyte composition of the test solutions : 
Parameter Krebs-Henseleit Control plasma Shock plasma 
Sodium 145.8 143.3 144.5 
(meq/l) 2 0.5 2.2 1 +
 
Potassium 4.5 4.3 7 .3^ ' °  
(meq/l) ^ 0 . 3  2  0.4 1 2.1 
Calcium 2.21 2.29^ 1 .92 ° ^ 
(meq/l) _+ 0.08 0.11 _+ 0.17 
Osmolarity 290.0 297.0^ 313.5°  
(mOsm/kg) + 4.'; + 4.4 + 6.7 
^ All values expressed as mean 2 S.D. 
Significantly different from Krebs-Henseleit; (p<0.05). 
Significantly different from Control plasma; (p<0.05). 
isotonic shortening of canine papillary muscles and calcium 
concentration has been reported by Hembrough et al. (1978). rfangensteen 
et al. (1973) and Goldfarb et al. (1979) have observed a similar 
relationship between isometric developed tension and calcium with feline 
papillary muscles. A \% change in calcium concentration produces 
approximately a \% change or less in tension or shortening. This 
relationship was also observed in two preliminary experiments in which 
the isotonic responses of canine papillary muscles were recorded at 
various calcium concentrations. In one of those experiments, the 
relationship between calcium concentration and maximum load (Po) was 
expressed by the formula Y = -0.11 + 12X (r = 0.996), where Y = the 
calcium concentration in g/100 ml and X = the maximum load (Po) in 
grams. Calcium versus velocity of contraction were related by the 
formula Y =0.17 +0.37 Z (r= 0.996), where Y = the calcium 
concentration in g/100 ml and Z = the maximum velocity of contraction in 
mm/sec. 
Osmolarity differed significantly between the three solutions. 
However, osmolarities as high as 350 mOsm/kg have not produced changes 
in muscle function when examined previously. This also is consistent 
with the data of Lefer and Inge (1973) and Goldfarb et al. (1979). 
Both plasmas were tested without modification of electrolyte or 
osmolar composition. The contribution of these electrolyte and 
osmolarity changes, in lieu of the evidence cited, may only be minor. 
However, all shock plasmas were very acidic and required addition of 
more 0.1 N NaOH in order to buffer them to pH 7.4. Control plasma 
required less buffering to adjust pH. Initial buffering to 7.4 was 
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transient and the pH needed constant adjustment throughout the 
experiment. The pH was constantly monitored and adjusted which may have 
minimized any effect of acidosis on the muscle. The pH of the chamber 
fluid was not allowed to decrease to less than 7.5. Continuous 
monitoring of pH in previous reported studies was not done. Therefore, 
an acidic condition may have been present during those bioassays despite 
initial adjustment of pH. Siegel and Downing (1970) have observed that 
acidosis does not affect isolated tissue function until a pH of 6.b or 
less was present or at higher pH when hypoxia was present. No effect of 
pH as low as 6.5-5.7 has been observed in some preliminary studies in 
which 1 N HCl was added to the muscle bath to reduce pH. However, an 
occasional muscle would respond to a few drops of 0.1 N HCl but then 
produced a control recording within several beats. Little effect of pH 
on muscle function over the range in this study would be anticipated as 
observed in previous studies by Goldfarb et al. (1979). 
Results of the bioassays with isotonically contracting canine 
papillary muscles have been summarized in Figures 6-14. All data have 
been expressed as mean S.D. A Student t-test was utilized to 
determine statistical significance. These experiments demonstrate that 
shock plasma may contain a depressant substance. 
Mean maximum loads (Po) recorded for each solution are shown in 
Figure 5. No differences were found between any of the solutions. 
Maximum load for the shock plasma was actually slightly greater than 
observed for either control plasma or K-H2. The activity of MDF has 
been defined in units equivalent to a decrease in the developed 
isometric tension by Brand and Lefer (1965). If peak developed tension 
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Figure 6. Maximum load (Po) recorded for each of the test 
solutions 
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Figure 7. Velocity of contraction or shortening versus afterload for all test solutions 
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Figure 8. Velocity of relaxation versus afterload for all test solutions 
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Figure 9. Effects of the test solutions on latency (LAT) 
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Figure 10. Effects of the test solutions on time to maximum velocity of contraction (TMVC) 
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Figure 11. Effects of the test solutions on time to peak of contraction (TPC) 
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Figure 12. Effects of the test solutions on time to maximum velocity of relaxation (TMVR) 
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Figure 13. Effects of the test solutions on duration of contraction (DUR) 
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Figure 14. Example of the typical relationship between the various time measurements 
over the range of afterloads tested 
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was the only criterion used, then it would be inferred that no 
depressant action was present. 
The relationships between afterload and the velocity of isotonic 
contraction (+dL/dt) and relaxation (-dL/dt) are shown in Figures 7 and 
8, respectively. Contractile velocities recorded for both K-H solutions 
were significantly greater than observed for shock plasma but not 
control plasma. Control and shock plasma were different only at the 
extremes of the afterload weights. In contrast, the relaxation velocity 
was significantly reduced over the entire range of afterloads relative 
to the other treatments when shock plasma was tested. The magnitude of 
this depression over the entire range of afterloads was not less than 
67%, 4-8%, and 45%, respectively, for K-H1 , K-H2, and control plasma. 
This compares with respective values of 54%, 40%, and observed for 
contraction velocity. Relaxation appears to be more sensitive to the 
depressant action of shock plasma. 
The latency times recorded over the range of afterloads for each 
solution are shown in Figure 9. There were no significant differences 
between any of the corresponding points on the curves for latency or for 
any of the other time indices. However, the time to onset of 
contraction was always slowest in the shock plasma. The shortest 
latencies were observed with the initial Krebs-Henseleit solution. The 
time to the maximum velocity of contraction (TMVC), time to peak of the 
contraction (TPC), the time to maximum velocity of relaxation (TMVR), 
and the duration of the contraction (DUR), shown in Figures 10, 11, 12, 
and 15, all demonstrate the same relationship as observed for latency. 
Shock plasma consistently caused longer times while the fastest times 
60 
were observed with K-H1. No differences between shock and control 
plasma and K-H2 were observed for the last three time indices, as shovm 
in Figures 11-13. This may suggest that the depressant may have more 
effect on latency. The final K-H solution was always tested after the 
two plasmas and yet the times were consistently faster than with the 
shock plasma. The very marked difference between K-H1 and K-H2 may be 
indicative of the progressive deterioration of muscle function with time 
or may represent irreversible damage produced by the shock plasma. The 
depressant nature of the shock plasma must be partially reversible or 
the response times to the K-H2 would not have improved. 
Figure 14 has been included to summarize the relationship between 
the various timed events in the contractile cycle with increasing 
afterload. The curves represent the same curves for K-H2 found in 
Figures 9-13- Latency and TMVC, which are indices of the contraction or 
shortening process become longer with increasing afterload. This is 
consistent with the expenditure of additional energy to overcome the 
system resistance, the intrinsic stiffness of the muscle, and the 
inertia of the afterload weight. The reverse occurs during relaxation 
as the heavier afterloads tend to break cross-bridges and restore the 
alignment of the papillary muscle to the preload length. 
This study established the depressant properties of fresh shock 
plasma derived from a canine hemorrhagic shock model similar to that 
incorporated into the early studies of Lefer and Martin (1970). The 
system for bioassaying the plasma was unique in several respects. The 
in vitro model was the young canine papillary muscle. Each muscle was 
tested with fresh control and shock plasma and referenced to pre and 
post recordings in Krebs-Henseleit. A diffuser system which had been 
designed and incorporated into the system facilitated high oxygen 
tension in the muscle bath without addition of antifoaming additives to 
the plasmas. Any effects of pH were minimized by the continuous 
monitoring and correction of change. 
Shock plasma does not affect maximum load but does produce a 
significant depression of relaxation velocity. However, whole plasma 
may contain many humoral agents, such as the catecholamines, which have 
positive inotropic properties and which may have antagonized any 
activity of the depressant factor on the myocardium. Subsequent studies 
were performed to isolate and bioassay the endogenous shock factor. 
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ASSESSMENT OF A MYOCARDIAL DEPRESSANT SUBSTANCE IN CANINE HOMOGENATES 
Introduction 
Plasma obtained from the shock experiments was subsequently 
subjected to partial separation by gel chromatography and then 
bioassayed on isotonically contracting papillary muscles. There was no 
consistency to the data and no conclusions could be inferred from those 
limited studies. Great variability was the norm in all experiments and 
no significant depression occurred in the assay of the individual peaks. 
Individual canine papillary muscles, in general, respond with some 
variation even when the recorded parameters are tested in the reference 
Krebs-Henseleit solution. The original protocol of this study had 
entailed individually screening each plasma from each respective shock 
experiment. However, the potential for added variability between 
samples may have further confused the attempts to localize depression in 
a chromatographed fraction. 
Additional factors were also considered which may have further 
contributed to the inconclusive findings. First, there was a period of 
between 90-120 days from collection and storage of the plasma until the 
first separations and the in vitro assessments. Second, the 
chromatography methods employed a chromatography column which limited 
the sample volume which could be applied to the column. The possible 
compounding effects of time and concentration superimposed on the 
variability between muscles could not be addressed without modifying the 
protocol substantially. 
Failure to observe marked and consistent depression could also have 
been due to the bioassay methods. Lefer et al. (1967) have employed 
isometric preparations of feline muscle with a stimulus frequency of 
60/minute and a temperature of 37 C. Canine muscles contracting 
isotonically at a frequency of 12/minute and at 27 C have been employed 
in our laboratory. Both methods enabled determinations of maximum 
isometric tension, hence the type of contraction was initially not 
deemed of significance. The canine has been used extensively by Lefer 
et al. as a source for MDF. Therefore, the canine bioassay model should 
be responsive to the depressant and the canine model was deemed 
appropriate. Conditions of temperature and frequency of stimulation had 
been previously assumed to have little influence on the response to the 
depressant. Brutsaert et al. (1970) and Mattiazzi and Nilsson (1976) 
have demonstrated that both conditions do have significant effects upon 
general muscle function. The effects of temperature and frequency of 
stimulation are two of the many physical factors affecting myocardial 
contraction which have been extensively reviewed by Blinks and 
Koch-Weser (1953) and Koch-Weser and Blinks (1963). 
Williams et al. (1969) have observed depression of peak developed 
isometric tension and contractile velocity of rat trabeculae at 37 C. 
Their results are consistent with observations by Lefer (1970) and Lefer 
and Rovetto (1970) for feline papillary muscles. However, no depression 
was observed by Williams et al. when the experiments were conducted at 
30 C. Therefore, the temperature of the muscle preparation was an 
important consideration in the evaluation of the depressant action of 
shock material. The experimental protocol was altered in lieu of the 
aforementioned concerns, the inconclusive findings, and the observations 
reported by Williams et al. 
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Ferguson et. al (1972) have previously employed pancreatic 
homogenates subjected to hypoxic conditions for isolation of MDF. They 
have observed comparable in vitro depression of papillary muscles in 
response to partially isolated fractions of either shock plasma or 
pancreatic homogenates. Improved standardization had the potential 
advantage of decreasing the variability observed with shock plasma. 
Therefore, experiments were conducted to generate depressant material 
from homogenated canine pancreas and then partially isolate the 
depressant fraction by gel chromatography. The effects of temperature 
and frequency on the response of papillary muscles to the depressant 
were then assessed in a subsequent study. 
Methods for homogenation and processing of the canine pancreas 
The pancreas was removed in separate experiments from four large 
dogs weighing 30.1 ^  ^-4 kg. Each dog appeared healthy prior to 
anesthetization with pentobarbital (25 mg/kg IV). A midline incision 
was made and the pancreas was carefully exposed to avoid unnecessary 
trauma. The pancreas was rapidly dissected free from the attached 
structures. It was placed in a cold saline solution to bathe the tissue 
and facilitate washing of blood and debris from the surface during 
transport. Any superficial connective tissue and fat was dissected from 
the surface and it was then washed with a modified Krebs-Henseleit 
solution equivalent in composition to that used for bioassay. Each 
pancreas was then blotted dry, weighed to the nearest 0.1 g, minced, 
mixed with fresh Krebs-Henseleit solution (1:6 w/v), and homogenized in 
a Waring blender for two minutes. This entire process took less than 
seven minutes. The pancreatic homogenate was quickly divided into two 
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fractions deemed "Control" and "Shock." Volumes of the respective 
solutions were determined. 
Control horaogenate was placed in a water bath at 80 C for 15 
minutes to denature the proteins. Debris was removed by centrifuging 
for 30 minutes at 16,000 x G at 4 C. Clear supernatant was removed, 
sealed in a polyvinyl jar, and frozen at -10 C. Shock homogenate was 
placed in sealed jars and incubated in a shaker bath at 37 C for 4-
hours. Thereafter, the Shock homogenate was processed like the Control. 
Samples of the supernatants were analyzed for osmolarity and 
calcium, sodium, and potassium concentrations. Osmolarity was generally 
about 10 mOsra/kg greater than determined for the Krebs-Henseleit 
solution. Shock homogenate was usually slightly higher than the 
Control. Sodium concentration in both homogenates was consistently 
lower than in the Krebs-Henseleit solution and measured between 125-130 
meq/l. Potassium concentration was in excess of 15 meq/l. This would 
reflect the cellular damage and release of potassium caused by 
homogenization. Calcium concentration was reduced to approximately 4.5 
mg/100 ml in the Control and 4 mg/100 ml in the Shock homogenate versus 
approximately 9.2 mg/100 ml for Krebs-Henseleit. It was concluded that 
these alterations in composition precluded any attempt to bioassay whole 
homogenate material. 
Respective homogenate material from each dog was thawed, mixed, and 
centrifuged to remove any debris. Equal volumes of each solution from 
each dog were then pooled and lyophilized to dryness overnight. The 
ratio of dried homogenate to volume of supernatant was 0.013 g/ml for 
Control and 0.022 g/ml for the shock material. Samples were sealed in a 
desiccator with desiccant and under a vacuum at -10 C until further 
processed and bioassayed. 
Fractionation of the homogenates 
The first step in fractionation was reconstitution of 0.456 g of 
dried material in 8 ml of distilled water. This value was derived from 
the average ratio of wet pancreatic weight/kg of body weight divided by 
the estimated blood volume/kg of body weight. The quantity of 
depressant substance reconstituted roughly extrapolated to 20 ml (e.g., 
20 ml X 0.013 g/ml) of blood which was to be collected in 10 ml 
fractions when chromatographed and assayed in a 10 ml chamber. 
Individual peaks were generally localized in 1-3 tubes. This would 
theoretically be equivalent to assaying approximately a 1-2 fold 
concentration of plasma, assuming the same quantity of homogenate 
derived depressant was present per unit of blood as during hemorrhagic 
shock. 
Reconstitued material was thoroughly dissolved and then 
ultrafiltered at 4 C through an Amicon 50 ml stirred cell mounted with 
Amicon Ui4-2 membrane. This membrane has a 1000 molecular weight cutoff 
Nitrogen at 55 psi was used to pressurize the cell. Usually, all but 
0.5-1.0 ml of fluid and filtrand was recovered. All the ultrafiltrate 
was layered on a glass barreled Econo-column with a 2.5 cm I.D. and 75 
cm length (Bio-Rad Laboratories). The column was packed with BioGel 
P-2, 200-400 mesh and maintained at 4 C in a cold room. This packing 
enabled separation by molecular weight over the molecular weight range 
of 100-1800 Daltons and has been used in the previous studies by Lefer 
and Martin (1969)- Flow through the columm was maintained constant at 
20 ml/hour by a Harvard Apparatus peristaltic pump. Flow rate was 
checked for 24 hours before and after a separation to verify the flow 
rate. Ten milliliter fractions were collected with an ISCO circular 
fraction collector set to cycle every thirty minutes. All glass columms 
and tubes for collection were siliconized (Siliclaid) to minimize 
peptide binding. A modified Krebs-Henseleit solution which was 
equivalent in composition to that used for bioassay less the glucose was 
used for eluting the samples. Fractionation required 24 hours and was 
timed to permit bioassay at about 22 hours after layering the column. 
Specific procedures for preparation of the column, maintenance, and 
calibration are described in the following section. 
Preparation of the chromatography peaks for bioassay 
The optical density of each fraction collected was measured at 250 
nm using matched quartz cuvettes and either a Beckman Model 21 or a 
Beckman DB-GT spectrophotometer. An elution chromatogram was then 
constructed and the peaks to be assayed selected. Small aliquots of 
each peak were taken for measurement of osmolarity by freezing point 
depression with an Advanced Osmometer. The calcium concentration was 
measured by the method described by Annino and Giese (1976). The 
calcium concentration was adjusted, if necessary, to that of 
Krebs-Henseleit with microliter quantities of a stock calcium chloride 
solution. Total change in volume of the chamber fluid did not exceed 1; 
change in volume per 10^ change in the calcium concentration. 
All samples were warmed to appropriate temperature, pregassed with 
95$ Og, 5% CC^ and adjusted to pH 7.4 with 0.1 N HCl or 0.1 N NaOH. 
Aliquots of the solutions were saved upon completion of the bioassay fo 
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subsequent determinations of sodium and potassium concentrations or 
réévaluation of the osmolarity or calcium concentration. 
Preparation of the chromatography columns 
Standard glass Econo-Column systems (2.5 cm I.D., 75 cm length, and 
568 ml nominal column volume)(Bio-Rad Laboratories) were siliconized 
prior to packing with Bio-Gel P-2, 200-400 mesh (Bio-Rad Laboratories). 
All polypropylene adaptors, funnels, caps and other acessories plus the 
polyethylene tubing were also siliconized. 
Dry Biogel P-2 was added to a deaerated modified Krebs-Henseleit 
solution without glucose which had been previously deaerated. The gel 
was then allowed to hydrate for four hours at room temperature. Most of 
the supernatant was removed and replaced with fresh Krebs-Henseleit 
solution and the gel was gently mixed again. This suspension was then 
deaerated at a low negative pressure for thirty minutes prior to pouring 
the column. The hydrated gel suspension was slowly and carefully added 
to a reservoir mounted on the column which had been previously filled 
with deaerated Krebs-Henseleit. The stopcock regulating column outflow 
was opened when approximately five cm of bed had formed. All subsequent 
operations were completed in a cold room at 4 C. 
The height of the column effluent tubing was adjusted to yield a 
zero hydrostatic pressure head. Column flow was then maintained at 20 
ml/hr by a Harvard Apparatus peristaltic pump connected in-line between 
the column and a four liter reservoir filled with deaerated modified 
Krebs-Henseleit solution without glucose. Flow was maintained at least 
24 hours or until the packed bed height was constant. Excess gel and 
the reservoir were removed and the column flow maintained and 
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periodically measured over an additional 48 hours. The excess BioGel 
was retained and periodically used to replace the top 5-5 cm of the 
column packing. 
Layering procedures 
All columns were allowed to flow a minimum of 24 hours prior to 
application of a sample. This permitted accurate measurement of the 
flow rate and elution of any residual contaminants. The tubing from the 
peristaltic pump was disconnected and the outflow tubing clamped over 
the fraction collector just prior to layering. Buffer was removed from 
the column down to the packing with a syringe fitted with a long piece 
of polyethylene tubing. The sample was slowly applied with another 
syringe to the side of the column and allowed to flow down at a rate 
which did not disturb the packing. When all the sample had been applied 
the column was connected to a second peristaltic pump which had been 
previously calibrated at the same rate but which pumped only air. The 
column was closely watched until the sample had just been absorbed into 
the packing. Small volumes of K-H were added to wash residual sample 
from the walls of the column. Approximately five ml of additional K-H 
were added after the washing had been absorbed and the column again 
connected to the system with the K-H reservoir for the duration of the 
elution. 
Maintenance of the column 
Columns were periodically cleaned with a 0.1% sodium dodectyl 
sulfate (SDS) solution. Approximately 10 ml were applied to the column, 
allowed to enter the packing, and then eluted with K-H for a minimum of 
72 hours (1.5 liters). The top 3-4 cm of column packing was replaced 
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when any discoloration or altered flow rate was noted. When the columns 
were not to be used for an extended period they were first cleaned and 
the flow rate was determined over several days. The pump was then 
stopped, the outflow closed, and the inflow opened to eliminate any 
pressure. Flow rate was determined when a column was in use again and 
never varied from the shutdown rate. 
Samples of the buffer on top of the column packing, the reservoir 
fluid, and the column effluent were periodically cultured for bacterial 
growth but were negative in all cases. 
Calibration of the column 
The void volumes of the columns were determined periodically by 
layering each column with bovine serum albumin (BSA). Concentrations 
and sample volumes ranged from 0.5 ml of a \% BSA + 3 ml of K-H to 1 ml 
of ^ 5 BSA + 3 ml of K-H. BSA was detected by measuring aliquots of each 
collected sample at an optical density of 230 nm with a Beckman Model 21 
Spectrophotometer. 
Molecular weight calibration was accomplished by applying the 
following compounds to the columns. 
1. Sulfamethazine (MW 278)(Nutritional Biochemicals Corporation): 
Sulfamethazine was prepared by adding the compound in excess to 
normal saline, thoroughly mixing, and allowing dissolution overnight 
in the cold room. The columns were layered with 3.0 ml of the 
saturated solution. 
2. Bacitracin (JIW 1411)(Nutritional Biochemicals Corporation): 
Bacitracin was prepared in saline at a concentration of 1 mg/ml. 
Columns were layered with 3.0 ml of the solution. 
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5- Phenol red (MW 375)(Hetheson, Coleman and Bell): One ml 
fractions of a saline solution containing 5 mg/ml of phenol red were 
applied. 
4. Angiotensin I (MW 1296.7)(Sigma Chemical Co.): Three ml 
fractions of a saline solution containing 5 mg/ml were applied. 
5. Oxytocin (MW 1001)(Anpro Pharmaceutical Co., Inc.): Three ml of 
the oxytocin solution at a concentration of 20 units/ ml were 
applied to the columns. 
All the molecular weight markers except phenol red were detected in the 
effluent samples by measuring the optical density at 230 nm. Phenol red 
was measured at 540 nm. 
Location of the salt peak has been of prime concern in prior 
studies. Therefore, the elution volume of the salt peak was detected by 
layering the column with three ml of a 1 M NaCÏ solution and then 
measuring the osmolarity of each sample collected. Location of the salt 
peak was routinely confirmed each time a test sample was chromatographed 
when the osmolarity of the peaks was determined. 
Methods for the Isometric Screen of Chromatographed Peaks 
Nine papillary muscles were prepared by the methods previously 
described for the bioassay of plasma and utilized to assess the effects 
of the respective peaks separated by gel chromatography. However, the 
bioassay system was modified to permit stimulating and recording 
isometric contractions.- Isometric preparations were employed to reduce 
the prolonged time required for completing afterload curves, to reduce 
the extensive time required for analysis of data, and hopefully to 
enable testing of all peaks on the same muscle. 
The bioassay system was the same as previously described except for 
the following modifications. An L-shaped muscle clamp was fabricated 
from a small block of Plexiglas mounted on the end of a large bore 
stainless steel tube. The plastic block was sectioned and two 21 gauge 
stainless steel tubes were embedded in the half of block secured to the 
large stainless steel tube. Holes were bored in the other half of the 
block which enabled the two halves to be pinched together securing the 
wall end of the papillary muscle. The opposite end of the large tubing 
was securely clamped to the hydraulic cylinder of a David Kopf 
Instruments, Inc. microdrive. Muscle length could be varied in micron 
units by raising or lowering the clamp. The upper chordae tendineae end 
of the papillary muscle was mounted with the same snare device described 
in the previous study and attached to a Grass model FT.03 force 
displacement transducer for recording isometric tension. Muscles were 
stimulated by one electrode placed parallel to the muscle and attached 
to the main stainless steel tube which supported the clamp and by a 
second electrode embedded in the surface of the clamp in intimate 
contact with the muscle. 
Solutions were gassed with 95io oxygen and 5% carbon dioxide which 
was bubbled through two 27 gauge stainless steel tubes inserted into the 
chamber bottom. Recirculation of fluid was accomplished by connecting 
the external fluid circuit to two additional 18 gauge tubes inserted 
into the chamber, such that fluid was returned to the bottom of the 
chamber and was removed from the top. This enhanced mixing of the 
chamber fluid. Oxygen tensions were monitored periodically and were in 
excess of 500 mm Hg. 
Each papillary muscle was equilibrated in modified Krebs-Henseleit 
for no less than one hour. All experiments were conducted at C and a 
stimulus frequency of 60 per minute. The muscle length was altered by 
extending or retracting the microdrive unit to which the muscle clamp 
was secured. Muscle length was initially increased in small increments 
until the developed tension began to decrease. Resting tension and 
developed or active tension were then recorded at each step as the 
length was decreased. These data were then fitted (least squares 
method) to Equations #1 and //2 with a computer in order to determine the 
length where maximum tension was developed (Lmax). Each muscle was then 
adjusted to 90^ of Lmax for the duration of the experiment. Muscle 
length and cross-sectional area were determined by the methods 
previously described. 
Testing of solutions 
The respective test solutions (either Krebs-Henseleit or the 
homogenate peak eluted in Krebs-Henseleit + glucose) were warmed to 
C, pregassed and adjusted to pH 7.4 prior to bioassay. Approximately 4 
or 5 peaks or portions of a peak were tested on each muscle. Every 
attempt was made to randomize the sequence for testing the respective 
peaks. Each solution was added to the chamber and the responses and pH 
monitored until a stable recording was obtained over a ten minute period 
and then the parameters were measured. Stabilization following each 
change of solutions was almost always rapid and was complete within 5 
minutes. The effects of time over the duration of the experiment were 
examined by comparing the respective K-H solutions paired with each 
peak. Effects of time on each comparison were negated by always 
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comparing the response to each peak to the subsequent K-H. This tended 
to underestimate any depression which occurred. Several exchanges of 
K-H were made following each peak to insure removal of any residual 
material. 
Recordings of stimulus artifact and isometric tension were made on 
a Beckman R6l1 polygraph. The auxiliary output of the isometric tension 
channel was differentiated and the change in tension per change in time 
(dT/dt) was also recorded. The transducer, which was linear up to 10 
grams (highest weight tested), was calibrated with known weights before 
each experiment and the calibration verified at the conclusion. 
Measurements made from the recordings are illustrated in Figure ? and 
are defined as follows. 
1. Resting tension (RT) = tension on the muscle due to changes 
in muscle length. 
2. Peak developed tension or active tension (AT) = maximum 
tension developed in excess of resting tension following 
stimulation and contraction of the muscle. 
3* Velocity of (contraction) developed tension (+dT/dt) = maximum 
rate of developed tension during contraction phase. 
Calculated from the slope of the polygraph tracing. 
4. Velocity of (relaxation) decline in developed tension (-dT/dt) 
Calculated from the maximum negative slope on the polygraph 
tracing. 
Results of the Bioassay of the Individual Chromatographed Peaks 
A typical elution profile of a sample of shock pancreatic 
homogenate together with the elution volumes of the various molecular 
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weight markers is shown in Figure 15- The elation volumes and molecular 
weights of the markers were fitted to an exponential regression equation 
and the molecular weights of the following chromatographed peaks were 
then extrapolated from the equation. 
Peak Molecular weight 
I 962 (range: 850-1000) 
II 732 
III 376-407 
IV 276 
V 187-218 
The elution volume of bovine serum albumin (BSA) was approximately 110 
ml which corresponded to a molecular weight of 1796. Therefore, B3A 
eluted at a volume that closely matched the upper exclusion limit (1800) 
for Biogel P-2. 
The characteristics of the muscles used to test the chromatographed 
peaks and the composition of the test solutions have been summarized in 
Table 5. The muscles had a mean length of 5-49 2. ^ «59 mm (mean ^  3.D. 
for all subsequent values) and a mean cross-sectional area of 1.39 2. 
2 0.50 mm . No significant differences were noted between muscles used 
to bioassay each peak. Likewise, there were no differences between the 
composition of the respective peaks. A majority of the samples which 
had been saved for electrolyte analysis subsequent to completion of this 
phase of the project were lost when successive attempts by our technical 
personnel to analyze them were unsuccessful due to equipment 
malfunction. Values obtained at a later date did not correlate at all 
with the anticipated results. This probably reflects contamination of 
Sulfamethazine (278) Phenol red 
(376) Bovine serum albumin 
g (69,000) 
1.0 M NaCl 
Bacitracin (1411) 
g Peak V 
Peak III 
Oxytocin (1001) 
4-1 
I 1 
Void volume 
(1800) 
Peak II 
Peak I 
Peak IV 
I 5 10 40 45 50 15 20 30 35 25 0
Elution volume (X 10 ml)^ 
f Molecular weight of calibration markers. 
Column packed with BioGel P-2, 200-400 mesh; 0.435 g reconstituted in distilled 
water and ultrafiltered (mol. wt. < 1000); filtrate layered on column and eluted with 
Krebs-Henseleit solution (without glucose). 
Figure 15. Typical elution profile of a pancreatic homogenate separated by BioGel P-2 
chronr.tography 
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Table 5- Characteristics of the muscles and composition of the 
respective chromatographed fractions 
PARAMETER 
Material 
Analyzed I 
Peak or 
II 
corresponding K-H 
III IV 
a 
V 
Length 
(mm) 
5.67^ 
+ 2.40 
5.o5 
2. 2 .1 7 
5.94 6.25 
+ 2.06 2.34 + 
4.65 
0.53 
Cross-sectional 
area (mm^) 
1 .24 
+ 0.51 
1.57 
+ 0.57 
1.56 1.45 
+_ 0.52 0.57 + 
1 .51 
0.59 
Calcium 
(meq/l) 
Peak 2.18° 
+_ 0.20 
2.28^ 
^ 0.05 
2.25® 2.28* 
+_ 0.01 +_0.13 + 
2.30* 
0.25 
K-H 2.33° 
+ 0.05 
2.28* 
+ 0.05 
2.25^ 2.28* 
0.08 + 0.03 + 
2.30" 
0.05 
Sodium 
(meq/l) 
Peak 143. 
1 1 .5 
149.3^ 
+ 15.4 
137.2^ 140.5® 
+4.4 +4.4 
140.0^ 
2 7.0 
K-H 141 .0 2 4.9 (for all peaks) 
Potassium 
(meq/l) 
Peak 5.2* 
2 0.2 
5.9^ 
1 1 .4 
. 5.1^ 5.2® 
2 0.2 _+ 0.3 + 
5.1* 
0.1 
K-H 5.0 +_ 0.1 (for all peaks) 
Osmolarity 
(mOsm/kg) 
Peak 275.) 
+ 2.9 
281 .0 
+ 12.6 
2!#.9 277.3 
+ 6.5 + 8.6 
277.d 
1 5.2 
K-H 274 .2 
+ 6.0 
273.8 
+ 6.9 
27j.5 272.2 273.3 
+ 6.7 
Muscle (n) 6 6 8 6 4 
^ Paired t-test for significance; no significant differences. 
All values expressed as mean S.D. 
^ Number of experiments = n-1 . 
Number of experiments = n-2. 
Number of experiments = n-'j. 
the samples or changes in composition due to repeated thawing and 
freezing or evaporation. Although limited samples were analyzed, the 
sodium and potassium concentration and the osmolarity tended to be 
higher in Peak II. This would be consistent with the elution of the 
salt peak at that same elution volume. The calcium concentation of 
Peak I was approximately 6% less than the corresponding K-H solution 
and was more variable ( _+ 0-^ mg/lOO ml) than the other peaks. A 
decrease in calcium concentration of ]% has been observed to decrease 
maximum isotonic load (Po) and peak developed isometric tension (active 
tension) about (unreported data). A small effect of decreased 
calcium concentration, although not substantial, must be considered in 
subsequent examination of the responses to Peak I. 
Results of the bioassay of each of the respective chromatographed 
peaks and the corresponding comparisons to the K-H solution are 
summarized in Table 6. There were no significant differences in muscle 
function between the respective groups of muscles when tested in K-H 
solution. The absence of notable differences in muscle characteristics 
between groups used to test the peaks, the composition of the test 
solutions, and the muscle function for each group assessed in K-H 
solution is interpreted as presumptive evidence that any effect of the 
respective peaks on muscle function was due to a myocardial effect or 
some component in the peak itself. 
When the responses of the muscles to the respective peaks, shown in 
Table 6, were compared to the responses in the corresponding K-H 
solution, only Peak I produced any significant depressant activity. 
Developed tension was significantly depressed by 30.4%, +dT/dt was 
Table 6. Results of the 
Ma terial 
PARAMETER^ Analyzed 
Resting tension Peak 
(RT) (g/inm2) 
K-H 
Developed (active) Peak 
tension (AT) 
(g/mm^) 
K-H 
Max. rate tension Peak 
developed ^+dT/dt) 
(g/sec/mm ) 
K-H 
Max. rate decline Peak 
in tension (-dT/dt) 
(g/sec/mm^) 
K-H 
Latency (LAT) Peak 
(msec) 
K-H 
oassay of respective chromatography fractions 
Peak or corresponding K-H 
I 11 III IV V 
+ o
 o
 
c
r
 
+ 
0.84 
0 . 5 2  + 
0.63 
0.29 + 
0. 60 
0 . 3 5  + 
0.83 
0 . 3 9  
+ 
o . y g  
0.44 + 
0 . 0 2  
0.46 + 
0.65 
0 . 3 4  + 
0.61 
0 . 3 3  + 
0.80 
0.36 
+ 
0 . 5 9 °  
0 . 5 5  + 
0 . 5 9  
0 . 5 6  + 
0 . 6 3  
0 . 3 9  + 
0 . 5 2  
0 . 3 4  + 
0.39 
0.50 
+ 
0 . 9 0  
0.86 + 
0 . 6 0  
0. b6 + 
0.59 
0.39 + 
0.48 
U . 2 9  + 
0 . 6 9  
0.54 
+ 
4.56°' 
3.42 
,d 
+ 
5 . U 2  
3.73 + 
7 . 7 3 d  
3.14 + 
6 . 3 5  
2 . 9 9  + 
6.42 
3.50 
+ 
5.92 
3.64 + 
5.72 
3.64 + 
6. 54 
3.17 + 
6.15 
2.65 + 
6. 38 
3 . 3 6  
+ 
6.66^ 
9 . 1 0  + 
7.24 
6.48 + 
8.70^ 
4.50 )-
 .31 
 . 2 5  + 
U.38 
6.62 
+ 
8.86 
9.14 + 
7.78 
7.52 + 
7.38 
4.03 + 
7.63 
5 . 0 9  + 
6 . 8 2  
4 . 8 3  
+ 
7 9 . 6 d  
11.3 + 
m . 0 ° '  
10.7 
id 
+ 
76.7^ 
9.4 + 
00.3 
_ 
+ 
7 6 . 3  
10. 1 
+ 
78.6 
5.2 + 
79.6 
10.1 + 
76.4 
1 1 . ;  + 
84. > 
10.7 + 
70.8 
9.4 
Time to mux. 
+dï/dt 
(msec) 
Time to peak 
tension (TPT) 
(msec) 
Time to max. 
-dT/dt 
(msec) 
Peak 
K-H 
Peak 
K-H 
Peak 
K-H 
15b.2^ 
+  6 1 . 1  
1 5 1 . 2  
± 36. j 
206.4^ 
_+ 40.0 
214.6  
24.1 
278. 
272.8 
+ 55.3 
149.3" 
1 30.0 
140.4 
^ 10.3 
210.0^ 
+ 19.3 
1  5 6 . 2  
104.9 
250.9^ 
267.8 
+ 26.9 
147.9"  
^29.3 
143.0 
^ 31.1 
224.3^ 
2  23.5 
214. 1 
1 24.9 
274.7^ 
265.4 
+ 50.4 
133. /  
+_ B.B 
135.7 
^ 4.2 
213.3^ 
+ 20.4 
213.3 
1 13.2 
25.7 
262.4 
+  10 .6  
1 5 6 . t  
45.5 
151 .0 
35.2 
219.0 
J:  29.9 
21 9.0 
29.1 
280.a 
272.5 
+ 59.7 
Duration (DUK) 
(msec) 
Peak 418.2 
+  4 2 . 2  
418.3 
+ 30.3 
442.1 
+ 42.9 
419.7 
+ 34.7 
424.3 
+  2 2 . 6  
K-H 423.6 
+ 35.1 
429.0 
I- 37.3 
439.0 
+  2 3 . 6  
425.3 
+ 38.3 
405.5 
+ 27.6 
Muscles (n) 8 
^ Number (n) for each parameter equals the number of muscles. 
All values expressed as mean S.D. 
Significantly different from corresponding K-H; (p<0.05); paired t-test 
for significance. 
number of experiments = n - 1 . 
decreased by 25.4%, and -dT/dt declined by 34.5 %. The magnitude of 
depression would have been even greater if data from one muscle with 
which Peak I had been tested had not been included in the statistical 
comparison. For example, Peak I depressed developed tension in that 
muscle by only 8.8% compared to a range of 20 to 52.9 % for the other 
five muscles. Whether the muscle was not responsive to the depressant 
or if there was a loss of activity in the peak could not be determined. 
Therefore, all muscles tested were incorporated into the statistical 
analysis. 
A significantly longer time to onset of contraction (latency) but 
shorter time to the maximum -dT/dt was observed when Peak II was tested. 
Although the changes were significant, it should be noted that Peak II 
did not produce a noticeable change from the previous solutions tested 
in two experiments. Therefore, one or two additional peaks were tested 
before K-H was added to the muscle chamber. The comparison between K-H 
and Peak II included some change which may not have been produced by the 
peak. Latency and time to peak tension (TFT) were shorter for Peak V. 
There was less than a 5% difference for both parameters. Since only 
four muscles were tested and some error in measuring latency times is 
inherent, any effect of Peak V is questionable. Neither Peak II nor V 
produced an effect which could be interpreted as myocardial depressant 
in nature. 
The relative magnitude of depression produced by the respective 
peaks was determined by expressing the data for each peak as a percent 
change from the corresponding K-H solution. The average percent changes 
for each respective peak are presented in Figures 16, 17, and 18. The 
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active tension in response to Peak I decreased despite no marked 
decrease in the resting tension. Considerable variation was noted in 
the relative effect of Peak III, although the mean response was a small 
increase in resting tension. These changes may have been caused by the 
corresponding shift in the resting tension. This pattern of net but 
variable increase in active tension with Peak III was of interest 
because it is consistent with countless observations made during 
preliminary studies with shock material obtained by multiple methods and 
from several sources. Bioassay efforts were previously concentrated on 
that peak for several reasons. First, there was similarity to the 
elution profile to that reported by A.M. Lefer (personal communication 
during a visit to our laboratory). Second, the early isolation of the 
samples eluted at that elution volume exhibited mild depressant 
activity. Finally, the molecular weight calculation had been in error 
and the error detected only after calibration and separation was 
performed on columns of different dimension (i.e., the columns used for 
the present study). 
Figure 17 illustrates the relative change in both +dT/dt and -dT/dt 
for the respective peaks. Depression was only observed with Peak I. A 
net increase in both parameters was observed for Peaks III, IV, and V. 
Peak II, which caused an increase in active tension, caused a 10% 
depression of the +dT/dt but only a small net depression of the -dT/dt. 
Peak II had a higher oamolarity and potassium concentration than the 
other peaks. However, osmolarity of approximately 375 mOsm/kg and 
potassium concentration of approximately 9 meq/l did not produce any 
changes in active tension, +dT/dt, or -dT/dt in preliminary studies. 
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Relative changes in the latency times are shown in Figure 18. 
Despite Peak I effects on active tension and dT/dt, there was no 
consistent effect on the latency time intervals. No significant 
differences or pattern were noted. A small and nonsignificant decrease 
in the time to the peak of the isometric contraction-was the only change 
in which Peak I appeared to differ in any way from the others. It is 
also possible that no changes would be anticipated because less tension 
(fewer cross-bridges) is developed. Formation of fewer cross-bridges 
(less tension) would require a shorter period to achieve maximum cross 
bridge formation. However, the decrease in +dT/dt caused by Peak I 
would imply that the rate of formation and turnover of cross-bridges 
would also be slower. Alternately, the failure to distinguish a 
significant effect on one of the latency times may reflect imprecision 
in measurement. At least two individual measurements of different 
contractions were made and the results averaged. While the measurements 
were usually quite close (less than 3^ difference), the substantial 
variability, which may be noted in Figure 18, may be the result of the 
inherent error in measuring distance on a small chart even with a 
measuring device reported accurate to ^ 0.025 mm. 
The effects of time over the 4-8 hour span of a typical experiment 
were evaluated by comparing the individual muscle responses to the 
respective K-H solutions tested following each peak. Results of these 
comparisons are presented in Figures 19 and 20. Although there was a 
tendency for active tension, +dT/dt, and -dT/dt to decline ; there were 
no significant differences between any of the four K-H solutions for any 
these parameters. It should be noted that the relative decline in 
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-dT/dt with K-H'5 and K-H4 appears to be of a greater magnitude than 
observed with +dT/dt. A consistent observation, in this and prior 
studies, has been the greater sensitivity of relaxation to either the 
depressant substance or the cumulative effects of time. All of the 
various latency times, shown in Figure 20, are consistent and do not 
seem to correlate with the changes in active tension or the generation 
and decline of tension. 
The ratio of active tension to resting tension was calculated for 
each muscle and K-H solution. These ratios were then statistically 
compared and no significant differences were present. When only the 
measurements for muscles in which all four K-H solutions were tested, 
the ratio ranged from 0.43 j^0.18 for K-H1 to O.'jY _^0.14 for K-H4. 
Deterioration of muscle function over time would not appear to be a 
factor in assessing the depressant properties of the respective peaks by 
the methods described. It should be recalled that each peak was 
referenced to a K-H solution which was subsequently assayed. Therefore, 
any negative effects of time were negated at the risk of underestimating 
the magnitude of depression. This means of comparison also eliminates 
any assessment of the reversibility of the depressant. 
The effects of isoproterenol (10 ^  M) on five of the papillary 
muscles were assessed after testing the respective peaks. The results 
are shown in Figures 21 and 22. Isoproterenol had no effect on resting 
tension but increased active tension by 70%, +dT/dt by 109%, and -dT/dt 
by 84%. These responses were consistent for all muscles tested. All 
latency intervals were shortened, although not significantly, by 
isoproterenol. Such observations are consistent with the anticipated 
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effects on myocardial tissue both in vivo and in vitro. The response to 
isoproterenol was transient with the peak response lasting no more than 
about one minute. Most of the muscles began to deteriorate rapidly 
following isoproterenol administration, despite repeated exchanges with 
fresh K-H solution. This irreversible damage may reflect the 
limitations on oxygen diffusion which is inherent in isolated muscle 
preparations. The increased metabolism induced by isoproterenol could 
exacerbate any limitation of diffusion and result in a hypoxic muscle. 
All the tested papillary muscles responded to the standard dose of 
isoproterenol even after 4-8 hours of experimentation. 
Conclusions 
Pancreatic homogenates subjected to shock-like conditions were 
separated into five fractions by gel chromatography. Only Peak I, with 
a molecular weight between 500-1000, had a depressant effect on the peak 
developed or active tension and both the rate developed tension, and 
relaxation of tension of isometrically contracting canine papillary 
muscles at conditions of '37 C and a stimulus frequency of 60 per minute. 
The molecular weight of Peak I is consistent with the range reported by 
Lefer and Martin (1969) for MDF. Location of the depressant in Peak I 
in the present study contrasted to the fourth peak (Peak D) for KDF. 
The difference in elution profiles, despite very similar methods which 
included the same ultrafiltration process and chromatography packing, 
cannot be explained. Possible explanations could include the 
differences in processing he homogenates, denaturation, differences in 
storage conditions, and the use of a pump to drive the separation. 
Peak I was the only fraction to significantly depress the active 
tension developed by the canine papillary muscles. Defer et al. (1967) 
quantitated the depressant action of MDF as depressant units, each 
equivalent to a decrease in peak developed or active tension. 
Therefore, even the magnitude of depression in the present study 
compares with the 30-50^ range for MDF. A lower concentration of 
calcium in the peak sample, although not significantly different from 
K-H, could not account for more than 10% of the observed depression. 
The depressant effect of Peak I on both contraction and relaxation 
velocity is also consistent with the observations in the initial 
assessment of shock plasma. 
This study confirms the presence of a depressant substance derived 
from a pancreatic homogenate which is either similar to or possibly MDF. 
Partial isolates of the pancreatic homogenate have not previously been 
reported to depress the contractile function of young canine papillary 
muscles, despite the frequent use of the canine as a source for such 
depressant material. Relaxation veloity has also been shown to be a 
reliable parameter for assessing the depressant property. Data obtained 
from subsequent studies relative to relaxation may provide important 
clues as to the mechanism of action of the substance. This phase of the 
project established the presence and location of the depressant in the 
chromatogram which facilitated a subsequent study of the interaction of 
the bioassay conditions of temperature and frequency of stimulation. 
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EFFECTS OF TEMPERATURE ON THE ISOMETRIC CONTRACTION OF CANINE PAPILLARY 
MUSCLES 
Introduction 
Langendorff (1895) and Snyder (1908) were two of the first 
researchers to report the inotropic effects of temperature on isolated 
cardiac muscle. A most comprehensive review of physical factors which 
affect muscle function, such as temperature and frequency of 
stimulation, has been written by Blinks and Koch-Weser (1965). Cooling 
has been shown by, Clark (1920), Hajdu and Szent-Gyorgyi (1952), 
Saunders and Sanyal (1958), Kelly and Hoffman (i960), Monroe et al. 
(1962), MacLeod and Koch-Weser (1963), Parmley and Sonnenblick (1969), 
Mattiazzi and Nilsson (1976), and Frist et al. (1978) to increase the 
strength of contraction and the duration of the contraction cycle over a 
temperature range of approximately 15-37 C. The time for cardiac muscle 
to reach peak tension also is prolonged, as reported by Reiter (1972). 
Kababgi and Schneider (1980) have not observed temperature, over a range 
of 22-38 C, to have any effect on resting muscle length or tension of 
unstimulated rat ventricular strips. They did observe increased 
resting tension with cooling down to 28 C when the muscles were 
electrically stimulated. Kruta (l938a, 1938b) has reported that the 
rate of shortening or isotonic contractile velocity is decreased as the 
temperature is reduced. . Brutsaert et al. (1970) confirmed a significant 
inhibition of maximum velocity of isotonic contraction by feline 
papillary muscles produced by cooling them from 37 C to 29 C. Maximum 
load was inversely related to temperature, although their results were 
not significant. A similar effect on the force-velocity curve was 
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reported for rabbit papillary muscle by Edman et al .  (1974).  Edraan et  
al .  suggested that temperature alters both the degree of activation of 
the contractile elements and the rate of interaction of the cross 
bridges.  Cooling also has a more pronounced effect on prolonging the 
relaxation phase of a muscle contraction than on the development of 
tension, as shown by Berne (1954),  Hirvonen (1955),  Hirvonen and Lybeck 
(1956),  and Goldberg (1958).  Finally,  prolongation of the duration of 
the myocardial action potential has been reported by Hollander and Webb 
(1955), Cranefield and Hoffman (1958), and Kelly and Hoffman (I96O). 
The effects of cooling on the action potential are more marked at lower 
stimulus frequencies and may be overcome by increasing the frequency. A 
review of the l iterature confirmed that temperature has a marked effect 
on cardiac muscle function both in vitro and in vivo. 
The shock homogenate derived depressant in the previous group of 
experiments was evaluated using an isometric preparation and protocol 
similar to Lefer et al .  (1967)* Subsequent experiments were planned to 
evaluate the interaction of temperature and frequency on the negative 
inotopic effect on canine myocardium using an isotonic preparation. 
However, a series of preliminary experiments were conducted to confirm 
the effects of temperature on the isometric contraction of the canine 
muscles util izing the bioassay system previously described. The 
responses of the isometric preparations could then be used as a means of 
comparison to the isotonic observations in the studies to follow. 
Methods: Examination of the Effects of Temperature 
Papillary muscles from fourteen young canine weighing approximately 
1.5-5 kg were prepared for recording isometric contractions by the 
methods described in the previous section. All  experiments were 
conducted using only the modified Krebs-Henseleit  solution, previously 
described, to bathe the muscles.  Muscles were equilibrated initially at 
either 27 or ' i l  C and a stimulus frequency of 12 per minute until  stable 
contractions were recorded over a 30 minute period. Equilibration time 
at 27 C required at least one hour more than at 37 C. Muscle lengths 
were subjectively adjusted towards Lmax until  the muscles had 
equilibrated. A preload curve was then constructed and used to set the 
muscle length to 90^ Lmax. All  subsequent experimentation was conducted 
at that length established at the initial  temperature. 
Temperature of the system was adjusted by resetting the thermostat 
which controlled the water bath temperature. The water was either 
heated or the water in the circulating bath was exchanged for cooler 
water and then heated to 27 C before being circulated. It  required less 
than three minutes after recirculating the water through the system for 
the bioassay system to reach the new temperature. All  muscles were 
equilibrated a minimum of 30 minutes after the system was adjusted 
regardless of the temperature and for at least 15 minutes of stable 
recordings when the initial  period was not sufficient.  The initial  
temperature was alternated between 27 and 37 C in successive 
experiments.  
Fresh Krebs-Henseleit  solution which had been pregassed at the 
appropriate temperature was added to the chamber to bathe the muscle at 
the beginning of each test.  The response at each temperature was 
recorded on the polygraph after stable recordings had been observed for 
20 minutes,  the temperature was readjusted, and the procedure repeated. 
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All measurements for tension and velocity were normalized for 
cross-sectional area. Data were statistically analyzed by a paired 
t-test for significance. 
Results and Discussion 
The results of the experiments have been summarized in Table 7-
These results clearly confirm the positive inotropic effect of cooling 
on cardiac tissue. Relative effects of cooling on muscle function, 
expressed as percent change from the parameter mean at 37 C, are 
summarized in Figure 23. Active tension was doubled by the decrease in 
temperature. In contrast,  the resting tension was essentially 
unchanged. All  of the measured time intervals to respective states in 
the contraction cycle were significantly prolonged by cooling. 
Insufficient data were collected for statistical evaluation of velocity.  
Although active tension and the time indices were all  significantly 
altered by cooling, i t  may be observed in Figure 23 that the largest 
quantitative changes were in active tension, latency, duration of 
contraction, and the time from peak tension to completion of the 
contraction. Lewartowski et al .  (1974) reported no difference in the 
Lmax of feline papillary muscles at 23 and 30 C and only a small 
decrease in resting tension with cooling. The absence of an effect on 
resting tension is  in contrast to the observations of Kababgi and 
Schneider (1980) for rat ventricular strips.  
The increased active tension observed with cooling has been 
attributed to an increased intracellular concentration of free calcium. 
According to Mattiazzi and Nilsson (1976),  free intracellular calcium is 
the net result of the rate of calcium release,  the duration of release,  
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Table 7.  Comparison of the effects of temperature on the isometric 
contraction of canine papillary muscles 
PARAMETER H 27 C 37 C 
Active tension (AT) 
(g/mm2) 
(n=U) 2.22*'* 
1 .60 
1.11 
10.93 
Resting tension (RT) 
(g/mm^) 
(n=U) 0.98 
2 0.48 
0.99 
^0.55 
Latency (LAT) 
(msec) 
(n=5) 70.2* 
+ 31.4 
34.6 
+ 24.9 
Time to maximum +dï/dt 
(msec) 
(n=5) 184.4^ 
+ 20.4 
124.6 
135.8 
Time to peak tension 
(TPT) (msec) 
(n=5) 375.0* 
^ 59.0 
209.8 
+ 25.6 
Time to maximum -dT/dt 
(msec) 
(n=5) 555.6* 
2 145.9 
292.6 
1 45.6 
Time for relaxation 
(TRLX) (msec) 
(n=5) 481 .8° 
i  159.1 
208.2 
1 31.5 
Duration 
(OUR) (msec) 
(n=5) 856.b* 
2 211.5 
418.0 
139.9 
TPr/TRLX (n=5) 0.82* 
2 0.19 
1.03 
1 0.22 
+dT/dt 
(g/sec/mm^) 
( n=3 ) 8.08 
+ 4.13 
9.22 
17.17 
-dT/dt 
(g/sec/mm^) 
(n=3) 5.89 
2 3.24 
10.06 
1 9.40 
Cross-sectional area 
(XSA) (mm^) 
(n=14) 1 .19 
+ 0.40 
^ All values expressed as mean _+ S.D. 
Significant temperature effect; (p<0.05).  
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Figure 23. Relative effects of cooling to 27 C on the isometric contraction 
of canine papillary muscles 
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and the rate of resequestration by the sarcoplasmic reticulum. It  is  
the amount of free calcium which interacts with the contractile elements 
to produce tension. The longer latency time at 27 C would imply that it  
took longer for sufficient sarcolemmal depolarization and a sufficient 
transcellular flux of calcium to trigger release of the intracellular 
stores of calcium. Although the duration of the action potential was 
not measured in these experiments,  i t  would be consistent with the 
prolongation of the contraction cycle.  Therefore, the critical 
sarcoplasmal calcium concentration would be maintained for a longer 
contraction. Finally,  i t  has been shown by Harigaya and Schwartz (1969) 
that cooling induces an inhibition of the reuptake of calcium by the 
sarcoplasmic reticulum. This inhibition and those of other enzymatic 
dependent processes of contraction and relaxation are thought to be 
additional mechanisms for maintenance of calcium levels which results in 
both increased cross-bridge formation and the duration of interaction. 
Relaxation can only occur when the sarcoplasmic calcium concentration 
falls.  The ratio between the time to develop and time to dissipate 
tension (time to peak shortening/time to relaxation) was calculated for 
each temperature and is  given in Table 7.  The relaxation process was 
longer at lower temperature and approximately equal to the contraction 
time at 'i l  C. Relaxation appears to be more sensitive than contraction 
to the influence of cooling. Langer and Brady (1968) proposed that the 
inhibition of relaxation could also be due to some undefined mechanism 
which overloads the ability of the relaxing system to remove the 
increased sarcoplasmic calcium concentration associated with muscle 
cooling. Relaxation of feline papillary muscles has been reported by 
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Frist et al .  (1978) to be more resistant to the effects of hypoxia at 29 
C than at physiological temperature. 
It  can be concluded from these experiments that canine papillary 
muscles are significantly affected by temperature. The response to 
cooling is  both qualitatively and quantitatively similar to values 
reported for muscle from other species.  The data obtained under 
isometric conditions provided a basis for comparing the effects of 
temperature on isotonic contraction to be examined in subsequent 
experiments.  Temperature does have significant effects on muscle 
function. The potential effects of temperature on the response to the 
depressant material were examined in the subsequent study. 
102 
INTERACTION OF TEMPERATURE AND FREQUENCY ON THE RESPONSE TO 
A DEPRESSANT FACTOR 
Introduction 
A myocardial depressant substance was identified in the previous 
studies which tended to confirm the findings of Lefer (1970),  Lefer 
(1974),  Lefer and Spath (1977),  Williams et al .  (1969),  Fisher et al .  
(1975),  Okuda and Fukui (1974),  Rogel and Hilewitz (1978),  Goldfarb et 
al .  (1979),  and Okada et al .  (1983).  'rfhole shock plasma from dogs 
subjected to hemorrhagic shock, but not control plasma or a modified 
Krebs-Henseleit  solution, was observed to depress maximum isotonic load 
and both contraction and relaxation velocity.  The depressant activity 
was partially isolated by gel chromatography in a molecular weight 
fraction corresponding to a molecular weight between 500-1000. This 
fraction or chromatography peak was subsequently shown to depress the 
peak isometric tension and the rate of tension onset and decline of 
isometrically contracting canine papillary muscles when the stimulus 
frequency was 50 per minute and at a preparation temperature of j7 C. 
These conditions were incorporated into the protocol of Lefer et al .  
(1967) for the assessment of the activity of myocardial depressant 
factor (MDF). 
The primary purpose of this study was to determine if  either 
temperature or frequency of stimulation of the isolated cardiac muscle 
preparation could be factors which influence whether the depressant 
substance produces a negative inotropic effect.  Depression has been 
reported in the l iterature primarily when conditions are more 
physiological ( i .e. ,  'j7 C and a stimulus frequency of 60 per minute).  
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The inotropic effects of temperature and frequency may mask the effect 
of the shock induced depressant substance at conditions of 27 C and a 
frequency of 12 per minute. Williams et al .  (1969) evaluated shock 
material on rat ventricular tissue and observed depression of peak 
isometric tension and velocity at 57 C and at a stimulus frequency of 60 
per minute. However, when the temperature was decreased to 30 C, no 
depressant effect was observed. The effect of temperature was not 
further evaluated. Absence of an effect at the lower temperature and 
frequency would confirm the observations by Urschel et al .  (1972).  They 
were unable to detect a depressant effect of shock derived material at 
the lower temperature and frequency. It  would also provide an 
explanation for the relative absence of any consistent depression 
observed in almost two years of frustrated efforts in our laboratory 
using many methods to identify a depressant of pancreatic origin in the 
canine, feline, bovine, porcine, and ovine. Finally,  i t  would help to 
resolve the controversy which sti l l  exists concerning the existence of 
an endogenous myocardial depressant substance. Although there are other 
possible explanations for the discrepancies,  temperature and stimulus 
frequency have been shown to alter muscle function and affect the 
response of isolated cardiac tissue to various inotropic agents.  
Physiologists and pharmacologists have traditionally studied 
cardiac tissue in vitro at temperatures less than physiological and at 
low frequency because of the greater stability of the preparation. 
However, the response to many pharmacological agents may not be uniform 
at all  temperatures.  Gotten and Cooper (1962) and Saunders and Sanyal 
(1958) have reported that the positive inotropic effects of the cardiac 
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glycosides are decreased by cooling. Similar observations have been 
reported by Booker ( i960),  Brora et al .  (1962),  Martinez and McNeil 
(1977),  and Duncan and Broadley (1978) for the catecholamines.  Webb 
(1950) observed that the negative inotropic effects of acetylcholine on 
rabbit auricle are increased by cooling. Blinks and Koch-'rfeser (1965) 
suggested in their review that the positive inotropic effect of cooling 
could theoretically increase the muscle contraction sufficiently that a 
pharmacological agent may not be able to cause any further increase in 
function. Cooling would be expected to alter the stiffness of the 
cellular components,  decrease the transmembrane fluxes of ions,  and 
inhibit the metabolic processes within the cell .  Inhibition of both 
active and passive processes would be expected to increase the duration 
of the contractile cycle but also sustain a high intracellular calcium 
concentration. This elevation of calcium is considered the mechanism 
for the positive inotropic effect of cooling. Velocity would be lowered 
and tension increased by cooling due to an increased sarcoplasmic 
calcium concentration. Karigaya and Schwartz (1969) have reported an 
inhibition of calcium uptake by preparations of cardiac sarcoplasmic 
reticulum as temperature is  decreased. Conversely,  at physiological 
temperature there would be no inhibition of enzymatic activity and the 
sarcoplasmic calcium concentration would be quickly lowered by the 
sarcoplasmic reticulum. Therefore, a negative inotropic effect should 
be more apparent.  Frist et al .  (1978) used this rationale to explain a 
more pronounced effect of hypoxia at physiological temperature. They 
hypothesized that a higher sarcoplasmic calcium is  maintained at low 
temperature which inhibits reuptake. The temperature effect 
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predominates and masks the inhibition of reuptake due to hypoxic 
inhibition of the metabolic mechanisms in the sarcoplasmic reticulum. 
Frequency has been reported by Abbott and Mommaerts (1959) and Hill  
(1951) to increase the degree of activation of cardiac muscle,  but 
Abbott and Mommaerts (1959) have also shown that the duration of the 
active state is  also shortened. Longhurst and McNeil ( i960) have 
confirmed these early observations. Koch-Weser (1965) has reported that 
the duration of the muscle action potential is  inversely related to 
frequency. The decrease in the duration of the contraction with 
increased frequency is  thought to decrease the entry of calcium per 
contraction, but the net calcium influx per time is  increased. As 
frequency is  increased beyond some critical rate,  the sarcoplasmic 
reticulum might not be able to reduce the sarcoplasmic calcium 
completely and a positive inotropic effect would be observed. Abbott 
and Mommaerts (1959) clearly demonstrated that increasing the frequency 
of stimulation shifted the force-velocity curve away from the origin. 
Brutsaert et al .  (1970) also observed a significant increase in both 
maximium load and velocity when the stimulus frequency applied to feline 
papillary muscle was increased from 12 per minute to 24-30 per minute. 
Sonnenblick (1962a, 1952b) earlier reported that the velocity increased 
relatively more than the strength or force of contraction. Relaxation 
velocity of guinea pig papillary muscles was shown by Kapel'ko et al .  
(1982) to be increased more than contraction velocity when the stimulus 
frequency was increased from 30 to 120 per minute. 
The interaction of temperature and frequency may produce a variable 
response by cardiac tissue. For example, Cranefield and Hoffman (195%) 
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have reported that increased frequency opposes the longer duration of 
both the action potential and the duration of the contraction produced 
by cooling. Further, Kruta (l938a),  MacLeod and Koch-Weser (1963),  and 
Koch-Weser and Blinks (1963) all  reported that when either temperature 
or frequency is  held constant,  there is  an optimum for the other 
variable at which contraction is  maximal.  
Frequency would be expected to affect the response of isolated 
tissue to inotropic agents.  Sanyal and Saunders (1958) and Mo ran (1962) 
have shown that many pharmacological agents,  such as the glycosides,  
have a more rapid onset of action at higher frequency. Drugs l ike the 
catecholamines,  strophanthin, acetylcholine, alpha adrenergic 
antagonists,  and metabolic inhibitors may produce positive,  no effect,  
or even a negative inotropic effect at different frequencies,  as 
reported by Lee (1954),  Vane (1957),  Furchgott and Sleator (1954),  
Katzung et al .  (1957),  Koch-Weser and Blinks (1962),  and Benfey (1979)* 
The potential for an interaction of temperature and frequency on the 
expression of any negative inotropic effect on the isolated canine 
myocardium is  well  supported in the l iterature. In general,  most 
published reports of depression produced by the various endogenously 
produced myocardial depressant factors,  l ike MDP, have been conducted at 
37 C and a frequency of 60 per minute. Negative findings, in contrast,  
were associated with lower temperatures.  The possible interaction of 
temperature or frequency on the response of the canine papillary muscles 
was evaluated in the following experiments.  
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Methods 
Source of the depressant material 
Pancreatic horaogenate material was drawn from the same pools of 
lyophilized homogenates described in the previous section. The methods 
for reconstitution and chromatographing the samples were also previously 
described. The f irst peak (Peak l)  was the only peak which exhibited 
significant depressant activity.  Therefore, testing in this study was 
restricted to a comparison of that peak to a modified Krebs-Henseleit  
solution at combinations of high and low temperature and frequency. 
Preparation of the samples for assay 
Separation of the samples by gel chromatography was timed to permit 
bioassay approximately 20 hours after the sample had been applied to the 
chromatography column. The osmolarity and calcium concentrations were 
determined prior to bioassay. Calcium concentration in the Peak 1 
sample (eluted in modified Krebs-Henseleit  less glucose) was adjusted to 
that of the Krebs-Henseleit  solution if  the concentration varied by more 
than 5%. Osmolarity of both Peak I and Krebs-Henseleit  and other peaks 
and tubes adjacent to Peak I were also measured. The osmolarities of 
Peak I  and Krebs-Henseleit  were always nearly identical.  
The bioassay system was the same one which was previously described 
for assessment of shock plasma. Samples were pregassed with 35% oxygen 
and 5% carbon dioxide by connecting the test tubes containing the 
respective solutions in series with the gas l ine used to gas the muscle 
bath. Tubes containing the samples were prewarmed to either 27 or 57 C 
by placing them in a block heater.  Sample pH was always checked with a 
pH meter and the sample regassed prior to adding the solution to the 
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muscle bath. The pH could be varied by changing the rate of gas 
bubbling or by the addition of 0.1N HaOH or HCl. However, the two 
solutions never varied more than 0.010 pH units.  Pregassing and 
temperature equilibration facilitated a very smooth exchange of 
solutions in the muscle bath and minimized the equilibration time of the 
muscle (approximately 30-60 seconds).  
Muscle bioassay 
Papillary muscles from nineteen young canines (thirteen for the 
shock derived material,  and six for the control) weighing approximately 
1.5-3 kg were prepared for recording isotonic contraction by the methods 
described for the assessment of shock plasma. î^Iuscles were equilibrated 
at the initial  combination of temperature and frequency to be tested 
until  stable contractions were recorded over a 30 minute period. 
Equilibration time at 27 C required at least one hour more than at 37 C. 
Muscle length was subjectively adjusted during the equilibration period 
to reflect a muscle length closer to Lmax. Preload curve data were 
obtained when the muscle was deemed equilibrated and used to compute 90 
% Lmax. All  subsequent experimentation was conducted at the muscle 
length (90$ Lmax) established at the initial  combination of temperature 
and frequency. Preload length of feline muscles is  not affected by 
temperature, as reported in Lewartowski et  al .  (1974).  Kababgi and 
Schneider (1980) have shown that the resting tension of rat myocardium, 
in contrast,  increases as the temperature decreases or frequency 
increases within the ranges employed in this study. 
Chromatographed Peak I samples of either control or shock pancreatic 
homogenate were tested at temperature and frequency of stimulation 
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combinations of either 27 or C and 12 or 60 per minute. Each 
experiment with shock homogenate was intended to test all  combinations 
of temperature and frequency. However, in preliminary studies it  was 
observed that high temperature was detrimental to canine papillary 
muscles.  This may have been due to the large muscle cross-sectional 
area typical of canine papillary muscles.  Oxygen demand would be 
greater at 57 C but delivery may have been compromised by the relatively 
large distance for oxygen diffusion. Therefore, the working l ife of an 
isolated muscle was reduced and sometimes only 2 or 3 comparisons could 
be made on a given muscle.  The sequence for testing combinations of 
temperature or frequency was partly randomized. Only one of the two 
factors was changed in sequence and the sequence for testing two 
specific treatment combinations was reversed in successive experiments.  
Specific test sequences were chosen in those experiments where all  
combinations could not be tested and it  was necessary to complete a 
minimum number of experiments within a treatment group and insure that 
the sequence for testing each treatment was equal.  
Temperature of the system was adjusted by resetting the thermostat 
which controlled the water bath temperature and exchanging the water in 
the water bath if  the subsequent temperature was to be lower. Actual 
equilibration of the muscle bath temperature required less than three 
minutes once the circulating pump had been turned back on. 
Equilibration time for the muscles after changing either temperature or 
frequency varied but was generally longer at low temperature and 
frequency of stimulation. A minimum equilibration period of at least 30 
minutes was observed at all  treatment combinations. 
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Procedure for testing 
Each muscle was tested only with material obtained from one 
chromatographic separation. Adjacent tubes which comprised Peak I  were 
pooled and the sample used to test at each respective combination of 
temperature and frequency was taken from that pool.  If  the volume was 
insufficient to enable each test to be performed with fresh solution, 
then some of the solution which had just been tested was added to the 
fresh solution to insure equivalent volumes. Several experiments were 
performed in which the depressant substance was removed, the muscle 
equilibrated in Krebs-Henseleit ,  and then the same depressant material 
was added back to the muscle bath. The responses appeared identical.  
Therefore, i t  was assumed that any reuse of small quantities of 
previously tested material would not adversely affect the results.  
Following addition of the test material to the muscle bath and 
adequate equilibration, the muscles were afterloaded. The f irst 
priority was to identify the maximum afterload (Po) which just prevented 
shortening. Muscles were more stressed with the temperature and 
frequency changes in these experiments than muscles used in the previous 
study. Recordings of muscle contracting in response to the heavier 
afterload weights were made sequentially without completely removing the 
afterload between individual weights to minimize the stress.  If  Po was 
approximately 4 g,  then approximately 0.5 g was removed and the response 
recorded following the recording at 4 g.  This would be repeated several 
times until  approximately 2 g remained. The afterload weights were then 
removed, the muscle was rested for ten contractions, and the next 
afterload weight tested. This procedure greatly reduced the time to 
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conduct the afterload measurements and noticeably reduced the incidence 
of muscle fatigue. 
Parameters which were directly recorded included stimulus artifact,  
isotonic shortening, and the isotonic shortening signal differentiated 
with time (dL/dt).  Frequent measurements of time, temperature, and all  
muscle afterloads were also recorded. All  responses were recorded on a 
Beckman R611 polygraph. It  should be noted that the pH of the 
circulating chamber was continuously monitored with an Orion Research 
Model 601A Digital pH meter and never varied. 
The response of the muscles to isoproterenol (lO M) was evaluated 
at the conclusion of all  experiments and referenced to the last 
Krebs-Henseleit  solution tested. Isoproterenol was tested as a standard 
reference and an indicator of muscle responsiveness following the 
stresses over time and also due to temperature and frequency changes.  
Muscle length and weight were measured and these values used to 
determine muscle cross-sectional area by the methods described for the 
bioassay of shock plasma. 
Analysis of results 
The recordings of the isotonic contractions were analyzed by the 
methods described for the bioassay of shock plasma (Measured parameters 
and calculations).  Each group of data was then fitted to a third order 
polynomial equation (Equation #6).  normalization of data between 
muscles was accomplished by calculating from each polynomial equation 
the respective values for each parameter which corresponded to ten 
percent increments of Po. 
Data were statistically analyzed by the ISU Statistical Consultation 
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Laboratory and with Daisy Professional by Rainbow Computing, Inc.,  a 
statistical software program designed to run on the Apple l ie 
microcomputer. Statistical comparisons were made with the appropriate 
application of a paired or unpaired Student t-test or the 
Mann-Vfhitney-Wilcoxon paired-signed-ranks test (Natrella (1953)) for 
nonparametric data. 
Results and Discussion 
The characteristics of the muscles and the composition of the 
solutions used for the bioassay of either the depressant peak from the 
shock or control homogenate are shown in Table 8.  There were no 
significant differences between any of the groups for any parameter 
except osmolarity.  The osmolarity of the control peak and the 
corresponding Krebs-Henseleit  solution were significantly greater tnan 
for other groups but not from each other. Raising the osmolarity by 
only 8 mOsm/kg should not have caused a detectable effect on any of the 
parameters subsequently measured. 
Effects of the control homogenate peak 
Examples of the elation profiles for the control and shock 
pancreatic horaogenates separated in these studies are shown in Figure 
24. Homogenate samples were reconstituted according to the formula 
defined previously in the study to assess the presence of a myocardial 
depressant in the horaogenates.  Shock homogenate separated into five 
distinct peaks, as previously reported. Only Peak I exhibited 
significant depressant activity.  Control homogenate rarely had any 
peaks except at an elution volume of approximately 300-360 ml. All  
identifiable peaks were bioassayed, but either did not depress the 
Table 8.  Summary of muscle parameters and solution composition for the 
assessment of temperature and frequency effects 
SHOCK HOMOGKNATK COWTKOL 
Parameter P12,2YCW F12,37G F60,27C F60, j7C All  samples 
Muscles (n) 
Length (mm) 
OrOSS-sectional 
area (mm^) 
Calcium (meq/l)  
Peak 
Krebs-Henselei t 
Osmolarity (mOsm/kg) 
Peak 
Krebs-HenseleiI 
b 
6 . y ^  
+  1 . 6  
1 .51 
+ 0.44 
2.39 
+_ 0.21 
2.40 
+ 0.22 
273.d 
1  5 . 1  
275.b 
+  5 . 5  
6.  U 
+ 1 . w 
1.34 
+ 0.26 
2.39 
1 0.24 
2.43 
+ 0.25 
272.0 
+ 4.3 
274.2 
+ 2.7 
11 
6 . 6  
0.9 
1 .52  
0.93 
2.29 
0.23 
2.41 
0 .18  
275.Û 
+_ 4.9 
275.5 
+ 3.6 
10 
7.0 
1  1 - 3  
1 .43 
+ 0.33 
2.28 
0.25 
2.42 
+  0 .  1 8  
275.2 
4.7 
275.1 
+  3 . 3  
6 . 2  
+ 0.8 
1.25 
+ 0.33 
2 .23  
+_ O.UB 
2.  19 
+ 0.  15 
263.0^ 
± 4.4 
28j.0C 
+  3 . 3  
^ K = frequency (12 or bO/minute); C = temperature ( 2'/  or 37 C )  .  
All  values expressed as mean +_ i î . l) .  
Significantly different from all  corresponding values for shock 
nomogenate,  (p<0.05).  
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Figure 24. Typical elution profiles of the control and shock 
pancreatic homogenates separated on BioGel P-2 
chromatography columns 
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papillary muscles or actually caused some improved function. The 
control elution volume corresponding to Peak II also had a greater 
osmolarity and contains the salt  peak. The profile for control 
homogenate does not include a detectable Peak I.  However, samples with 
the equivalent volume were bioassayed. 
Control pancreatic homogenate which had been processed and 
separated by the same methods used for the shock pancreatic homogenate 
was bioassayed on six muscles.  The results of these experiments have 
been summarized in Table 9'  Although each experiment was designed to 
test all  four combinations of temperature and frequency, the number 
successfully completed for each ranged from one to f ive.  Therefore, the 
data were pooled by either frequency or temperature. For example, 
experiments at both frequencies conducted at 27 C were pooled and 
statistically compared to the pooled data at 57 C. 
Control pancreatic homogenate exhibited very l ittle effect on any 
parameter at any combination of temperature and frequency. Improved 
function was not uncommon. The effects of the control homogenate peak 
have been expressed as a percent change from the corresponding 
Krebs-Henseleit  solution and are shown in Figures 25 and 26. Maximum 
load was not significantly affected at either condition of temperature 
or frequency. If  all  the data were pooled, then only a 2.45  ^  10.8% 
increase (stimulation) of maximum load was observed. Contraction 
velocity (shortening velocity) also was not affected by frequency. 
However, contraction velocity increased 4.6 _+ 0.1% when the pancreatic 
homogenate fraction was tested at 37 C compared to a decrease of 7.7 ^ 
9.3% observed at 27 C. Relaxation velocity was not altered when the 
Table 9« Summary of the effects of the control homogenate peak, frequency, and 
temperature on muscle function 
PÀRAMKÏEH^ 
Po Vc Vr LAÏ TMVC TPC THVR DUK 
(g/mm^) (g/sec/mm^) (msec) 
PREQ = 1 2/ininute (n=6) 
Control Peak 2.68 2.94^ 8.07 70 204 4)5 571 819 
_+ 1 .25 1 .96 +_ 8.40 ^ 57 82 85 ^ lOj 145 
Krebs-Henseleit  1.87 3.12 8.04 70 194 429 555 797 
2 1 .07 2 2.15 i  8.55 2^ jj  2^ 90 80 111 152 
PREQ = 60/minute (n=4) 
Control Peak 2.47 4.85 8.94 67 151 jU1 516 592 
0.91 2 2. j7 15.14 1 17 75 ^121 ^ 145 _+ 231 
Krebs-Henseleit  2.18 5.26 7.65 72 150 362 507 681 
+ 0.70 + 2.01 + 5.70 +18 + 57 + 108 + 159 + 255 
THJIP = 27 C (n=B) 
Control Peak 2.68 3.42 8. y5 73 194 463 607 822 
+ 1 .2% + 1 .59 + 0 . 93 1 +
 
+ 90 1 27 +_ 36 + 64 
Krebs-ilenseleit  2.57 3.81 7. 56 7j 1 78 448 602 83'/ 
+ 1 .26 + 1 .bj + 7. 27 1 ^ 78 +_ 38 1 55 1  84 
TEWP = i l  C (n=2) 
Control Peak 1 .20 4.85 9.  16 55 160 257 362 491 
+ 0.48 + 4.90 + 9. 42 1 12 1 15 i 21 + 19 + 85 
Krebs-Henseleit  1 .18 4.bj 9. 54 63 152 261 349 480 
+ O.j? + 4.68 + 9. 75 1 4 1 1 26 1 21 1  94 
® Statistics applied for comparisons where n = 4 or more; no significant differences.  
All  values expressed as mean S.D. 
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Figure 25. Effects of frequency and temperature on the relative change in maximum 
load and velocity in response to the control homogenate peak 
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Figure 26. Relative effects of frequency, temperature, and control homogenate peak 
on latency times 
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fraction was tested at either temperature but significantly increased 
from a net depression at low frequency (-O.j +_ 12.59'/®) to a net 
activation (28.93 2. 26.47%) at high frequency. Temperature and 
frequency had no effect on the various latency times of the muscles in 
response to the pancreatic homogenate,  as shown in Figure 26. 
Relatively l ittle net change from Krebs-Henseleit  solution v;as 
observed for the chromatographed fraction of control pancreatic 
homogenate which corresponded to the shock homogenate fraction evaluated 
in the isometric screen of the peaks and which was further evaluated in 
this study. The control homogenate could have and probably should have 
received a more extensive evaluation. Although the number of 
experiments was l imited by availability of quality muscles and an 
adequate supply of the original lyophilized control homogenate for 
subsequent separation, there was a consistent lack of substantial 
depression. This especially contrasted to the,effects on relaxation 
velocity observed in the subsequent evaluation of the shock homogenate 
peak. Control pancreatic homogenate did not appear to contain a 
myocardial depressant substance. 
Effects of the shock homogenate peak, frequency, and temperature 
The data from the experiments to evaluate frequency and temperature 
effects on the response to the shock homogenate peak have been 
summarized in Figure 27 and Tables 10 through 16. All  recorded velocity 
and time data from the individual experiments were normalized for 
cross-sectional area and f itted to a third order polynomial equation. 
Values were then extrapolated from the fitted equation at 0.1 increments 
of maximum load (Po).  The coefficients of the equations have not been 
4 
o 
Ph 
D -
to (N 
O £ 2 -
; ^ 
I 1 
F12, 27C G'b 
(n = 8 ) 
3 _ 
F12^_37C 
( n = 6 ) 
d,e 
+ 
F60, 27C 
(n=ll) 
F60, 37C 
(n=10) 
Peak K-H Peak K-H Peak K-H 
TREATMENT 
Peak K-H 
^ All values expressed as mean _+ S.D. 
F = frequency (12 or 60/minute); C = temperature (27 or 37 C). 
Significant difference between indicated pairs; paired t-test for significance; (p 0.05) 
significance; (p<0.05). 
Significantly different from other means with the same letter; (p<0.05). 
^ Significantly different from K-H at F60, 27C; (p<0.05). 
Significantly different from K-H at F60, 37C; (p<0.05). 
Figure 27. Summary of the effects of shock peak, frequency, and temperature on 
maximum load (Po) 
Table 10. Summary of the effects of shock homogenate, frequency, and temperature, 
on contraction or shortening velocity 
Normalized Relative Load (P/Po)^ 
.OP 0.1P 0.2P Oo'P 0.4P 0.5P 0.6P 0.7P O.UP 0.9P 
Note: velocity at 1 .OP = 0 
FHEQ 12, 27G (n=8)'^ 
Shock Peak 
VELOCITY (mm/sec/mm^) 
2.05'^'® 1 .75® 104® 1.29® 1.18® 1.04 0.90 0.73 0.54 0.29 
j^1.34 4^ 1 .1?) _+ 0.97 0.65 0.76 j_ 0.68 jt^O.bl _+ 0.52 0.40 _+ O.Zj 
Krebs-Henseleit 
2.48 2.13 1.85 1.61 1.39 1.20 1.01 0.82 0.60 0.35 
+_ 1 .73 1.1.45 11-22 1 .03 _+ 0.88 ^ 0.75 ^ 0.b4 ^ 0.52 ^ 0.39 ^ 0.24 
FHEQ 12, 37C (n=6) 
Shock Peak 
1 . 8 1 ®  1.68® 1.57® 1.49® 1.38 1 . 2 6  1 . 1  0.92 0 . 6 8  0.39 
+ 0.72 + 0.69 + O.bb + 0.64 + 0.60 + 0.55 + 0.48 + 0.40 + 0.31 + 0.20 
Krebs-Henseleit 
2.16 2.05 1.92 1.76 1.58 l.jW 1.16 0.93 0.68 0.43 
+ 0.84 + 0.70 + 0.96 + 0.53 + 0.48 + 0.44 + 0.42 + 0.41 + 0.40 + 0.3b 
FREQ 60, 2YC (n= n  )  
Shock Peak 
j.U8 2.42 1.95 1.U3 1.58 U  i l  1.U8 0.y5 0.Y2 0.45 
+_ 2.14 1 .78 +^1.78 ^ 1.50 1 .27 +^0.87 +^0.71 +_0.56 +^0.41 
Krebs-Henseleit 
3.16 2.68 2.j0 1.98 1.72 1.48 1.25 1.01 0.75 0.44 
+_ 2.27 11.90 ^l.bO 11.'54 11.12 i 0.97 10.95 1 0.62 i 0.47 1 0.27 
PREQ 60, 57C (n=10) 
Shock Peak 
2.82® 2.54 2.50 2.09 1.89 1.69 1.46 1.18 0.87 0.47 
1 1 .97 11.74 1 1 .56 1 1 .40 l 1 .26 i1.11 i 0.95 1 0.76 1 0.54 l 0.29 
Krebs-Henseleit 
5.06 2.69 2.58 2.12 1.87 1.64 1.59 1.15 0.85 0.46 
+ 1.95 + 1.57 +1.51 +1.12 + 0.99 +0.89 + 0.79 +0.68 + 0.55 + 0.51 
^ Calculated as 0.1 increments of Po for respective solutions normalized 
for cross-sectional area. 
PREQ = frequency (12 or 60/minute); C = temperature (27 or 57 C). 
Calculated as follows: recorded velocity versus afterload data were 
fitted to third order polynomial equation and velocities then extrapolated from 
the equation at 0.1 increments of Po. 
All values expressed as mean 1 S.D. 
® Significantly different from Krebs-Henseleit, (p<0.05). 
Table 11. Summary of the effects of shock homoyeriatu, temperature, and frequency on 
relaxation velocity 
Normalized Relative Load (P/Po)^ 
.OP 0.1P Û.2P O.'jP 0.4P 0.5P 0.6P 0.7P O.BP O.yP 
FREQ 12, 27C 
HBLAXA'flOU VELOCITY (mm/sec/nun^ )° 
Shock Peak 
4.08^'^ 4.65® 13.16® 5.09® 4.69® 4.06® j.27® 2.':?8® 1 .4B® 0.62® 
+2.69 + 3.65 +4.17 +4.24 +3.97 +3-45 +2.73 +1.99 +1.27 +0.59 
Krebs-Henseleit 
5.74 6.69 7.06 6.95 6.41 5.b0 4.55 3.37 2.15 0.98 
3.86 + 5.22 + 5.90 + 5.96 + 5.53 + 4.80 + 3.84 + 2.80 + 1.77 + 0.80 
FHEQ 12, 37C (n=6) 
Shock Peak 
3.01® 2.W9® 2.75® 2.57® 2.36® 2.10® 1.81® 1.46® 1.06® 0.59 
1 .77 + 1 .55 + 1 .36 +_1.18 ^1.02 ^ 0.87 0.74 0.63 0. 50 ^ 0.36 
Krebs-Henseleit 
4.92 4.85 4.M 4.29 3.84 3.>1 2.72 2.09 1.45 0.81 
+ 2.38 + 2.18 + 2.02 + 1.85 +1.66 + 1.43 + 1.18 + 0.92 + 0.09 + 0.63 
FRblQ 60,  21C ( n = l l )  
Shock Peak 
4.62 4.WO 4.76 4.52 4.12 2.93 2.22 1.44 0.72 
+_ 2.60 2.9,5 j.04 2.yj 2.64 2.22 1.74 1 .25 0.b4 0. )9 
Kreba-Henseleit 
5.49 5.60 4.46 b.11 4.59 J.94 j.20 2.39 1.56 0.76 
2 ).35 >.50 j.53 j.35 2.98 ^ 2.48 1 .92 11.56 ^ 0.84 ^ 0.58 
FREQ 60, 370 (n=10) 
Shock Peak 
5.80 5.87 5.66 5.23 4.62 3.89 3.07 2.20 1.39 0.62 
15.31 1 5.59 1 5.44 l 4.92 i 4.16 i 3.26 i 2.34 1 1.51 1 0.87 1 0.40 
Krebs-Henseleit 
6.43 6.36 6.04 5.52 4.85 4.07 5.23 2.37 1.54 0.78 
+ 3.79 +4.05 + 4.15 + 3.99 + 3.60 +3.03 + 2.36 +1.67 + 1.04 +0.52 
^ Calculated as 0.1 increments of Po for respective solutions normalized for 
cross-sectional area. 
fREQ = frequency (T2 or 60/minute); C = temperature (27 or 37 C). 
^ Calculated as follows: recorded velocity versus afterload data were fitted 
to a third order polynomial equation and velocities then extrapolated from the 
equation at 0.1 increments of Po. 
All values expressed as mean 1 S.D. 
® Significantly different from corresponlin,-; Krebs-Henseleit, lpKU.U5). 
Table 12. Summary of the effects of shock homogenate, frequency and 
temperature on latency 
Normalized Relative Load (P/Po)^ 
.OPo .U2Po .04Po .05Po .OBPo 
PREQ 12, 27C (n=8)b 
LATENCY (msec)' 
Shock Peak dV'' 14'j® 186® 227 283 
+ 2U +15 +24 +41 + !;) 
Krebs-Henseleit ^ 84 1?8 179 219 21j 
+^ 14 1G ^21 +^ 26 i 2y 
PREQ 12, 37C (n=6) 
Shock Peak t>9 85 10b 127 15^ 
5  l y  1  10  +^  1 2  ^ 1 7  
Krebs-Henseleit ^ bb db 104 124 148 
+  b  + 7  + 8  +  y  + 1 7  
FREQ 60, 27C (n=11) 
Shock Peak 70 124 154 101 222 
^ 1 2  ^  17  2 0  2 1  _+  2 3  
Krebs-Henseleit ^  75 11j 145 176 215 
2 1 1 16 4^ 17 4^ 1W +. 21 
FREQ 60, )7C (n=10) 
Shock Peak 61 80 102 125 149 
+^14 14 8 ^17 ^14 
Krebs-Henseleit i 57 80 101 122 147 
+  + 1 5  + 1 8  + 2 1  + 2 5  
^ Calculated as 0.2 increments of Po for respective solutions 
normalized for cross-sectional area. 
b FREQ = frequency (12 or 60/minute); C = temperature (27 or yi C). 
c Calculated as follows; recorded time versus afterload data were 
fitted to third order polynomial equations and time then extrapolated from 
the equation at 0.2 increments of Po. 
d All values expressed as mean S.D. 
® Significantly different from corresponding Krebs-Henseleit; (p<0.05) 
^ Significantly different from g, h, and i at all afterloads; (p<0.05) 
S Significantly different from h and i at all afterloads; (p<0.05). 
Table 1Summary of the effects of shock homogenate, frequency and 
temperature on time to the maximum velocity of contraction (ïMVC) 
Normalized Relative Load (P/Po)^ 
0 0.2PO 0.4PO 0,6Po O .8P0 
FHEQ 12, 27c (n=8)b 
THVC (msec)G 
Shock Peak 21 id 
1. 52 
2:)9 
1 6) 
274 
+_ 70 
'?15 )64 
1. 
Krebs-Henseleit 209 
1 
225 
^ 59 
275 
1 
^oy 
1 51 2 54 
EREQ 12, )7C (n=6) 
Shock Peak 177 
1 
17; 
+ 28 
184 
2 2b 
205 
+ 28 
22y 
+ 25 
Krebs-Henseleit® 167 
+ 28 
1 70 
+ 26 
181 
+ 28 
1 yy 
+ 2y 
224 
+ j2 
FREQ 60, 27C (n=11) 
Shock Peak LYU 206 
1 36 
226 256 292 
+ )6 
Krebs-Henseleit®'^ 187 
+ 40 
1 yy 220 
1 29 
24U 
+ 28 
27J 
1 21 
FREQ 60, T/C (n=10) 
Shock Peak 154 
+ 
155 171 
1 :)2 
1 y4 
1 
214 
_+ 40 
Krebs-Henseleit®'^ 14D 
+ ^6 
1 59 
+ >5 
1 72 187 
+ :)0 
204 
+ 26 
^ Calculated as 0.2 increments of Po for respective solutions normalized 
for cross-sectional area. 
FKEQ = frequency (12 or 50/minute); C = temperature (27 or yf C). 
Calculated as follows: recorded time versus afterload data were fitted 
to third order polynomial equations and time then extrapolated from the 
equation at 0.2 increments of Po. 
All values expressed as mean ^  S.D. 
® Significantly different from Krebs-Henseleit at FREQ 12, 27C at all 
afterloads; (p<0.05). 
Significantly different from Krebs-Henseleit at FREQ 12, 'j7U at all 
afterloads; (p<O.Ob). 
Table 14" Summary of the effects of shock homogenate, frequency and 
temperature on time to peak of contraction (TPC) 
formalized Relative Load (P/Po)^ 
0 0.2PO 0.4PO O .6P0 O .8P0 
FREQ 12, 27c (n=8)^ 
TPC (msec)^ 
Shock Peak 439* 
2 )4 
445 
+_ 44 
453 
1 51 
457 
1 !^ 7 
453 
+ 60 
Krebs-Henseleit 434® 435^ 
i 42 
440® 
i 31 
444® 
+ b>6 
440® 
L 53 
FRBQ 12, j7C (n=6) 
Shock Peak 
f 
2 4 2  
1. 
f 
237 
i 13 
f 
235 
1  1 2  
f 
234 
1 12 
238 
1 17 
Krebs-Henseleit 245^ 
+ 13 
240^  
+ 12 
236^ 
+  1 2  
234^ 
+ 13 
235'^ 
+ 1 50 
PREQ 60, 27C (n=11) 
Shock Peak J49 
1 ^5 
M5 
1 30 
Mb 
± 32 
34^ 
JL 
343 
1 ^2 
Krebs-Henseleit 326^ 
+ :)6 
520^ 321 
1 27 
325 
1 25 
325 
1 29 
FREQ 60, j7C (n=10) 
Shock Peak 206 21) 
28 
219 222 
1 ^4 
224 
1 52 
Krebs-Henseleit 208^ 
+ jO 
209^ 
+ 51 
21 1 
+ 31 
212 
+ 31 
21 1 
+ 32 
^ Calculated as 0.2 increments of Po for respective solutions normalized 
for cgoss-sectional area. 
FKEQ = frequency (12 or 60/minute); C = temperature (27 or 37 C). 
^ Calculated as follows; recorded time versus afterload data were fitted 
to third order polynomial equations and time then extrapolated from the 
equation at 0.2 increments of Po. 
All values expressed as mean _+ 8.D. 
® Significantly different from all other K-H solutions; (p<0.(J5). 
Significantly different from corresponding K-II solution; (p<0.05). 
® Significantly different from K-H solutions at i'REQ 60,27C and t'KEQ 
60,j7C; (p<0.U5). 
Significantly different from K-H solution at FREQ 60,27C; (p<0.05). 
Table 15- Summary of the effects of shock, nomo^enato, frequency and 
temperature on time to maximum velocity of relaxation (TMVH) 
Normalized Relative Load (P/Po)^ 
UPo 0.2PO 0.4PO 0.6P0 0.8P0 
FRKQ 12, 27c (n=a)^ 
THVR (msec) 
Shock Peak 562 ^ 582 57 j 555 
79 46 ^ 45 66 
Krebs-Henseleit 51 562 ® 564 ® 56 j ® 544 ® 
54 2 51 2 49 62 68 
FREQ 12, YfC (n=5) 
Shock Peak 351 ^  j45 ^  'j40^ jj4 ^  j26 ^  
+_ ^2 ^28 26 27 +_ 30 
Krebs-Henseloit 349 ^  342^-' 333® >23^' 313® 
+ 30 + 29 + 32 + ;4 + 27 
FREQ 60,  27c  (n=11)  
Shock Peak 500 
1 
4% 
^ 43 
472 
+ 48 
4by 
47 
442 
2 43 
Krebs-Henseleit 460^ 
44 
446'' 
+ 46 
441 
4!p 
435^ 
+_ 41 
420 
+_ 40 
FREQ 60, 37c (n=10) 
Shock Peak 3 1 1  
+ 2U 
307 
+ 29 
302 
1 30 
2% 
2 30 1 io 
Krebs-Henselei t 298 
+ 42 
2% 
+ 37 
292 
+  3 4  
269 
+ 35 
265 
+  4 0  
^ Calculated as 0.2 increments of Po for respective solutions normalized 
for cross-sectional area. 
^ PHEQ = frequency (12 or 60/minute); C = temperature (27 or 37 C). 
^ Calculated as follows: recorded time versus afterload data were fitted 
to third order polynomial equations and time then extrapolated from the 
equation at 0.2 increments of Po. 
All values expressed as mean S.D. 
® Significantly different from all other K-H solutions; (p<0.05). 
oignificantly different from corresponding Krebs-Henseleit; (p<0.0^). 
® Significantly different from K-li solution at FfiliQ 60,2'/C and PREQ 
60,370; (p<0.05). 
Significantly different from K-11 solution at FREQ 60,j7C; (p<0.U5). 
Table 16. Summary of the effects of shock homo,';eriate, frequency and 
temperature on duration of contraction (DUR) 
FREQ 12, 270 (n=a)^ 
Shock Peak 
Krebs-Henseleit^ 
FREQ 12, T/C (n=6) 
Shock Peak 
Krebs-ltensoleit 
Normalized Relative Load (P/Po) ^  
0 0.2Po 0.4PO O.bPo 0.8Po 
PUR (msec)^ 
U04^ 6 / 5  6Yl 6J8 625 
1 71 1 41 44 1. 6l 1 7) 
7uy 649 6 1 4  62 j 6oy 
^2 2 45 +_ 46 1 ';7 1 67 
552^ 440^ 402^* 968 
1 74 ^ 49 1 ^ 6 1 + 45 
';57 440 394 yi8 
+ 64 _+ bU 1 52 54 +_ 4 y 
FRBQ 60, 27C (n=11) 
Shock Peak 698 561 
+ 66 
51 6 
1 56 
512 
^ 48 
498 
1 51 
Krebs-Henseleit® b47 
+_ 04 
557 
+ 65 
4yj 
1 52 
4% 
1 52 
475 
1 49 
I'RliQ 60, yiC (n=10) 
Shock Peak 42V 
+ 48 
378 
+ 44 
356 
^ 4j 
347 
+_ 44 1 47 
Krebs-Henseleit^ 
+ c
 o
 
j62 
+ 51 
3)5 
+ 46 
jj2 
+ 47 + 46 
^ Calculated as 0.2 increments of Po for respective solutions normalized 
for cross-sectional area. 
FHEQ = frequency (12 or bO/minute) ; G = temperature (2? or ')! C). 
° Calculated as follows: recorded time versus afterload data were fitted 
to third order polynomial equations and time then extrapolated from the 
equation at 0.2 increments of Po. 
All values expressed as mean +_ S.D. 
^ All Krebs-Henseleit means significantly different from corresponding 
mean at other temperatures and frequencies; (p<O.Ob). 
Significantly different from corresponding K-H solution; (p<O.Ob). 
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given, but the correlation coefficient of the fit was almost always in 
excess of 0.95 for the velocity curves, latency (Lat), time to maximum 
velocity of contraction (TMVC), and duration (Dur). The various time 
data presented in Tables 12 through 16 have been reported only for 0.2 
increments of Po because the shape of the curves did not exhibit marked 
changes between those points. 
Effects of frequency and temperature on the isotonic contraction 
of canine papillary muscles measured in Krebs-Henseleit solution 
Figures 27 through )0 illustrate the effects of combinations of 
temperature and frequency on muscle function measured in the 
Krebs-Henseleit solution. The changes in maximum load (Po) are shorn in 
Figure 27* The temperature effects are consistent with those observed 
in the previous section for the isometric preparation and confirm those 
reported in the literature by Parmley and Sonnenblick (1969), Hattiazzi 
and Nilsson (1976), and Frist et al. (1978). Decreasing the temperature 
produced a significant positive inotropic effect at both frequencies. 
Further, the temperature effect is more prominent at low frequency. A 
significant positive inotropic effect was also observed when the 
frequency was increased at 57 C but not at 27 C. Faster delivery of the 
stimulus would be expected to mobilize more calcium per time. Likewise, 
increasing the temperature might be expected to increase both 
transsarcolemmal calcium flux and intracellular ion mobility and raise 
the free calcium necessary for contraction. However, increasing the 
temperature should also increase efficiency of the metabolic machinery 
which lowers sarcoplasmic calcium levels via calcium reuptake by the 
sarcoplasmic reticulum. The lower maximum load at 57 C is evidence 
^ 1 
© F12, 27Ca,b 
Q B F12, 37C 
F60. 27C 
• F60, 37C 
OPo 0.2PO 0.4PO O . 6 P 0  O . 8 P 0  
Normalized relative afterloaa 
Po 
^ Mean response at each afterload. 
F = frequency (12 or 60/minute); C = temperature (27 or 37C). 
^ Significant effect of frequency at 27C from 0.3-0.8Po; (p<0.05). 
Calculated as 0.1 increments of Po for each respective solution and 
normalized for cross-sectional area. 
Calculated as follows: recorded velocity versus afterload data were 
fitted to a third order polynomial equation and velocity then extrapolated 
from the equation at 0.1 increments of Po. 
Figure 28. Relationship between afterload and contraction or shortening velocity 
at combinations of frequency and temperature 
27C 0F12, 
BF12, 
F60, 
OPo 0 .2Po 0 .4Po 0 . 6Po 0.8PO 
Normalized relative afterload d 
Po 
Mean response at each afterload. 
F = frequency (12 or 60/inlnute); C = temperature (27 or 37C). 
j Significant effect of frequency at 27C from 0.5-0.8Po; (p<0.05). 
Calculated as 0.1 increments of Po for each respective solution and normalized 
for cross-sectional area. 
Calculated as follows: recorded velocity versus afterload data were fitted to 
a third order polynomial equation and velocity then extrapolated from the equation 
at 0.1 increments of Po. 
Figure 29. Relationship between afterload and relaxation velocity at combinations of 
frequency and temperature measured in Krebs-Henseleit 
4001 
5200-
.2Po 4Po .6Po .8Po 
G-
-OF12, 27C (n=8) 
-QF12, 37C (n=6) 
« ®F60, 27C (n = ll) 
m 8F60, 37C (n=10) 
400 
TMVC 
B20Q. 
.2Po 4Po .6Po .8Po 
600-1 
500-
^00-
£ 
Q) 
H 
200-
lOCM 
TPC 
0— 0 —e— 9 o 
#— 
Q 
B • 
II
I II
I Q 
B 
7001 
TMVR 
!" 500-
9 400-
2 0 0  
2 P o  . 4 P o  , 6Po 8Po 
oioOO-
Normalized relative afterload 
0  . 2 P o  . 4 P o  . 6 P o  . 8 P o  
Normalized relative afterload 
-p-
o 
a 
b 
Mean response at each afterload. 
Statistical significance has not been shown as the differences have been reported in 
Tables 12-16. Most means were significantly different. 
F = frequency (12 or 60/minute); C = temperature (27 or 37C). 
Calculated as 0.2 increments of Po for each respective solution. 
Calculated as follows: recorded time versus afterload data were fitted to a third 
order polynomial equation and velocity then extrapolated from the equation at 0.2 
increments of Po. 
c 
d 
e 
Figure 30. Summary of frequency and temperature on the time to various phases of the isotonic 
contraction recorded in Krebs-Henseleit 
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which supports the dominance of the later process at 37 C. Tension 
developed or the number of cross bridges formed is a direct function of 
the cytoplasmic calcium concentration which is lowered as temperature is 
increased. Temperature and frequency are inversely related in the 
potential of each factor to produce an inotropic effect on the canine 
muscle preparation. 
The relationships between afterload and both contraction and 
relaxation velocity at the combination of frequency and temperature 
measured in Krebs-Henseleit solution are shown in Figures 28 and 29-
The fastest contraction velocity was observed at both temperatures when 
the frequency was 50 per minute. However, the difference was only 
significant over the middle range of afterload. Although little 
significant difference between treatments was observed, the contractile 
velocity at a constant frequency was usually fastest at low temperature 
at afterloads less than 0.2Po. As the afterload weights were increased 
in excess of 0.2Po, the velocity tended to be faster at high 
temperature. Whether this frequent observation is real and not artifact 
or if this relates to differences in muscle stiffness, calcium release, 
or calcium reuptake is speculative at best. 
A significant effect of frequency was the only observed difference 
in relaxation velocity, as shown in Figure 29. Considerable variation 
in maximum relaxation velocity over a range of approximately 1-20 mm/sec 
was observed. Maximum velocity was observed at approximately 0.2-0.3Po. 
This was a more consistent observation at lower temperature. Peak 
velocity at 0.2-0.3Po was also observed in the experiments to examine 
shock plasma and further confirms the observations of Strauer (1973) and 
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Strobeck et al. (1975) with isotonic preparations of feline papillary 
muscle at temperatures of 24 and 29 C, respectively. Strobeck et al. 
have suggested that this phenomenon may be caused by increased stress 
placed on those cross-bridges which are intact during the relaxation 
process. Fewer bridges are being formed and the afterload would tend to 
break those remaining at a faster rate. A maximum rate at any afterload 
would be a function load, extent of activation, and the rate of calcium 
sequestration. 
Relaxation velocity was fastest for all conditions at low 
temperature and frequency but slowest when the temperature was 
increased. This observation would seem to be contradictory to a faster 
reuptake of calcium at higher temperature. If the responses in Figure 
29 for both temperatures at a frequency of 60/minute are compared, a 
slightly faster relaxation velocity occurred when temperature was 
increased. It is possible that the curve for F12, 27C may represent an 
artifact due to a proportionately greater number of muscles in that 
group which exhibited very high relaxation velocities. It should be 
reemphasized that each muscle could not always be tested at all 
combinations of temperature and frequency. No other explanation for 
this observation is apparent at this time. This study was conducted to 
evaluate the interaction of temperature, frequency, and the shock peak 
and not specifically temperature or frequency. Primary comparison of 
these factors was subsequently accomplished by normalizing the results 
by expressing them as a percent change from the paired response in 
Krebs-Henseleit solution. 
The effects on the various time intervals are shown in Figure 30. 
U5 
Latency was shortened at constant frequency over the range of afterloads 
tested when the temperature was increased. In contrast, increasing the 
frequency shortened latency only at 27 C . Latency is a measure of the 
time from delivery of the stimulus until sufficient calcium has been 
mobilized for contraction to begin. Therefore, a faster frequency or a 
lower temperature would help to maintain the calcium concentration 
closer to the critical threshold and shorten latency. The other times 
to the various phases of the contraction cycle were also temperature 
sensitive over the entire range of afterloads. TMVC, TPC, THVR, and 
duration were all shortened by raising the temperature to 57 C. An 
increase in frequency also significantly shortened all parameters at 
both temperatures except for TMVC at 27 C. Temperature had a more 
pronounced effect than frequency on altering time in the contractile 
cycle. 
Latency, TMVC, and duration all appear to be load dependent. As 
the amount of afterload is increased, a proportionately longer time 
would be required to develop sufficient tension for muscle shortening to 
begin. Therefore, both load dependence of latency and TMVC (which is a 
measurement of shortening velocity) would be expected. Gravity acts on 
the afterload weight hung on the opposite end of the isotonic muscle 
lever. This force aids in the relaxation process by exerting a shearing 
force which tends to break cross-bridges and restore the resting 
sarcomere length more rapidly. Muscles do not shorten as much with 
heavier afterload which minimizes the number of potential cross-bridges 
which may be formed during the relaxation or lengthening phase of the 
cycle. Therefore, both of these factors would be expected to contribute 
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to a decrease in the duration of the contraction. The time to the peak 
of the contraction (TPC) does not vary with the relative amount of 
afterload and appears to be load independent. Ti'IVR also is relatively 
constant over the range of afterloads, although a subtle trend to 
decrease with increasing afterload is shown in Figure 30. 
Effects of frequency and temperature on the response of the 
papillary muscles to the shock peak The interaction of shock peak, 
frequency, and temperature on maximum load has been summarized in Figure 
27. The shock peak caused a significant depression of maximum load at 
all combinations of temperature and frequency except at 'il C and a 
frequency of 12/minute (F12,57C). Although the same isotonic 
preparation was utilized in the bioassay of shock plasma, no significant 
depression of maximum load was observed in those studies. However, 
depression of peak isometric tension was observed in the studies 
conducted to determine the presence of the shock fraction in the 
chromatographic separation. Whole plasma may contain other substances 
expected to have positive inotropic effects on the muscle. Any such 
influence was removed by the chromatographic separation of the 
ultrafiltered homogenate. The isotonic muscle preparation must develop 
isometric tension equal to the afterload before shortening can occur. 
Shortening requires formation of new cross-bridges as the sarcomere 
length decreases and is more energy costly. The concentration of the 
depressant in both the isometric and present isotonic study were 
theoretically the same. Therefore, it is possible that the isotonic 
preparation may be more sensitive to the depressant. 
The presence of the depressant factor was confirmed by the observed 
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depression maximum load caused by the shock homogenate peak but not the 
control homogenate peak. In order to determine if there were 
differences in the relative amount of depression produced by 
combinations of temperature or frequency, the recorded effect of the 
shock peak on maximum load at the various conditions for each experiment 
was expressed as a percent change from the recorded response to 
Krebs-Henseleit solution and statistically compared. These results are 
summarized in Figure 51• Despite a lack of statistical difference 
between the two solutions, the largest percent depression (approximately 
23%) was observed at low frequency and the higher temperature (F12,j7C). 
An increase in frequency at a given temperature did not cause any 
significantly different response, but a trend towards less depression 
was observed. 
The interactions of frequency, temperature, and shock peak on 
contraction and relaxation velocity have been summarized in Tables 11 
and 12. The shock peak produced significant depression of contraction 
or shortening velocity primarily at low frequency for a constant 
temperature. However, depression was only observed at afterloads less 
than one half maximum load. This observation would appear to be 
contrary to what might have been anticipated. Intuitively, diminished 
function caused by the shock peak via the undefined mechanism would be 
expected to have a more pronounced effect at heavier afterloads. More 
cross-bridges would need to be formed and the energy expenditure 
increased. Therefore, these results may reflect some artifact created 
by expressing data which differ in magnitude between individual muscles 
a s  m e a n  +_  S . D .  R e l a x a t i o n  v e l o c i t y ,  w h i c h  i s  s u m m a r i z e d  i n  T a b l e  1 1 ,  
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^ All values expressed as mean + S.D. 
Comparisons are significantly different; (p<0.05). 
Figure 31. Effects of frequency and temperature on the 
relative depression of maximum load produced 
by the shock peak 
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was significantly depressed over the entire range of afterloads but only 
at low frequency. 
The velocities have been expressed as percent change from K-H 
solution in Figures 52 and 33» A frequency induced relative depression 
of contraction velocity at 27C with no additional afterload was the only 
significant observation. If the magnitude of depression of contraction 
velocity at each condition is compared, depression at low frequency was 
twice that observed at the faster frequency over the range of 
afterloads. A trend towards less depression with increasing afterload 
may also be observed in Figure 52. 
Relative changes in relaxation velocity are presented in Figure 55-
The predominant effect was that of frequency. At a constant temperature 
the amount of depression at a frequency of 12/minute was double that at 
60/minute. Higher temperature also tended to cause more depression, 
especially at a frequency of 60/minute. There was comparatively littlu 
difference in relaxation velocity between the shock peak and 
Krebs-Kenseleit at FdO,27C. Under those conditions, a theoretically 
higher concentration of free calcium over time would be anticipated due 
to increased calcium mobilization induced by frequency and an 
anticipated low temperature induced inhibition of calcium reuptake by 
the metabolic dependent process of the sarcoplasmic reticulum. This 
contrasts with the more pronounced effect at F12,57C where less calcium 
would be available over time. The depression effect on velocity appears 
to be antagonized at experimental conditions which raise the cytoplasmic 
calcium levels. This further confirms the observations of Defer and 
Rovetto (1970) that supplemental exogenous calcium can reverse the 
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^ Significant difference between indicated means; (p<0.05). 
F = frequency (12 or 60/minute); C = temperature (27 or 37C). 
^ Calculated as 0.1 increments of Po for respective solutions. 
Recorded velocity data fitted to a third order polynomial, the velocity was 
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Figure 32. Relative change in shortening or contraction velocity due to the shock peak 
and combinations of frequency and temperature 
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Figure 33. Relative change in relaxation velocity due to shock peak and combinations of 
frequency and temperature 
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depression caused by HDF. When the magnitude of depression for maxinurn 
load and contraction and relaxation velocity are compared for any given 
condition, the observation that relaxation velocity is the primary 
parameter affected by the depressant peak is again confirmed. 
The relative changes calculated for the various time intervals have 
been summarized in Figure '34- Prolongation of the LAT, TMVC, TMVR, and 
DUR was observed over the entire range of afterloads. However, there 
were no significant differences between the effects of combinations of 
frequency and temperature on the response to the shock peak. A trend 
towards a slower TMVR at higher frequency, especially at 27 C, was the 
only consistent pattern observed. 
Relative change in the TPC produced by the shock peak was 
significantly affected by combinations of temperature and frequency. 
The shock peak caused a prolongation of the TPC at 27 C, but this effect 
was antagonized by raising the temperature to 'il C. Effects of 
temperature were most pronounced at the higher frequency of 60/minute. 
The effects of cooling on prolonging the TPC of the muscles tested in 
Krebs-Henseleit solution are illustrated in Figure jO. Cooling would be 
expected to slow the mobilization of calcium for contraction and to 
inhibit the enzymatic processes for formation and cleavage of 
cross-bridges. The prolonging of the TPC at F6û, 27C by the shock peak 
could imply that alteration of either of these schemes is a possible 
mechanism for the depressant. Shortening the TPC at F60, 37C must also 
be reconciled. Elevating the temperature may sufficiently activate a 
key enzymatic process or slow the rate of calcium release and mask any 
inhibition of the depressant. This hypothesis would not seem likely 
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Figure 34. Relative change in the various time phases due to the shock peak and combinations 
of frequency and temperature 
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because changes in the TPC must be reconciled with a quantitative 
depressant effect on cardiac muscle. Greater relative depression was 
observed at 37 C. If maximum shortening were reached earlier in a 
muscle but the degree of shortening was quantitatively less, then fewer 
cross-bridges would be formed and less work would be done. In this 
later case, cooling would afford some protection by prolonging the pulse 
of available calcium. 
The shock peak caused further prolongation of the TPC at 27 C wiien 
frequency was increased. At 37 C the frequency effect is reversed and a 
shortened TPC was observed. Neither temperature nor frequency influenced 
the TPC with increasing afterload of muscles tested in Krebs-Henseleit, 
as shown in Figure 30. However, the shock peak caused a progressive 
reduction in the TPC with increasing afterload at F60, 37C. The 
interaction of temperature and frequency alters the effects of the shock 
peak on TPC. 
Effects of isoproterenol on muscle function at different 
frequencies and temperatures Isoproterenol was added to the 
Krebs-Henseleit solution in the muscle chamber at the conclusion of all 
other testing and the response recorded. Final concentration in the 
— Ô 
chamber fluid was 10 M. Complete afterload curves were done in seven 
of the muscles. Determinations of maximum load (Po) and the response 
with no afterload were made in the remaining muscles. There were 
insufficient numbers in all groups representing combinations of 
temperature and frequency for statistical comparisons. Selected data 
have been summarized in Table 17 and the relative change in the measured 
parameters produced by isoproterenol is shown in Figures 35 and 36* 
Table 17- Nummary of the effects of isoproterenol at different froquenciea 
and temperatures on isotonic muscle function 
PARAMETER 
J)M2, 
130P 
270'i.b, 
K-H 
° I'M 2 
ISOP 
,yic 
K-H 
F60, 
lUOP 
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FbO 
liJOP 
,yic 
K-H 
Max. ^Oad 
(g/mm ) 2 2.'j\ 
2.;4 
2 2.49 
1.11® 
+_ 0.22 + 
O.bj 
0.25 
2.808 
0.7a 
2.24 
_+ 0.5% 
1 .«2^ 
j_ 0. 25 
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All responses except'for maximum load were recorded with no afterioad. 
^ Parameters were previously defined in Figure j. 
° F = frequency (12 or 60/min); C = tempei-ature (27 or >7 C) . 
All values expressed as mean S.D. 
® Significant effect of isoproterenol; (p<0.05). 
No statistics applied for groups with n<j. 
750-
--600-
OJ 
(0 
g 
2%50. 
Q) 
M 
* 
«300-
44 
O 
• 
F12, 27C B'b 
F12, 37C 
F60, 27C 
F60, 37C 
c 
I  1  
gl50. ' ' r-^ 
-• -IniÉ-B- zc. 
Maximum Load Velocity Contr, Velocity Relax, 
^ All values expressed as mean 2 S.D. 
F = frequency (12 or 60/ininute); C = temperature (27 or 37C). 
Significant difference between indicated pairs; (p<0.05). 
Figure 35. Relative changes in maximum load and contraction and relaxation 
velocities in response to frequency, temperature, and isoproterenol 
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Figure 36. Relative changes in lagency times in response to frequency, temperature, 
and isoproterenol (10 M) 
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Maximum load (Po) and both contraction (shortening) velocity and 
relaxation velocity with no afterload added to the muscle were all 
increased by isoproterenol. Increasing the frequency appeared to have 
little effect on either contraction or relaxation velocity, but maximum 
load was reduced at 27 C. In contrast, a more rapid stimulus appeared 
to have a pronounced effect on maximum load and both velocities at j7C. 
Isoproterenol had the greatest effect at the combination of higher 
temperature and frequency. Further, when the relative changes in 
velocity are compared for all combinations of temperature and frequency, 
the magnitude of change in relaxation velocity is greater than 
contraction velocity. 
The effects on the time to various events in the isotonic 
contraction cycle of isoproterenol relative to K-Ii solution are shown in 
Figure 36. Considerable variation and small sample numbers precluded 
any definitive conclusions. However, isoproterenol did shorten the 
respective times in the experiments. It should be noted that even these 
modest changes may represent a decrease of almost 50 msec and would be 
expected to have a marked effect on the availability of calcium for 
contraction. Isoproterenol did not appear to greatly change the time to 
peak shortening (TPC) at any combination of temperature or frequency, 
although the considerable difference in the absolute TPC can be observed 
in Table 17- The dominant effect at all combinations was to decrease 
the time to the onset of contraction (LAT) by 25-50%. This would 
confirm that these preparations can respond to catecholamine stimulation 
after as much as eight hours of in vitro experimentation. There is 
insufficient data to determine whether temperature or frequency altered 
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the response to isoproterenol. However, the greatest decrease in all 
times was also observed at the combination of higher temperature and 
frequency. 
A consistent observation following administration of isoproterenol 
was a rapid and often irreversible deterioration of the papillary 
muscles which was most evident when the preparation was tested at 
primarily 57 C but also at 60 stimuli/minute. Neither repeated washing 
with fresh Krebs-Henseleit solution nor altering the temperature or 
frequency prevented the loss of function. Isoproterenol increases 
metabolism via g-adrenergic stimulation. The added demands on oxygen 
diffusion to the muscle core probably exceeded the availability to 
deliver oxygen and probably resulted in permanent damage due to a 
hypoxic core in the muscle. 
Evaluation of the papillary muscles with isoproterenol did confirm 
that the muscles were responsive to a positive inotropic agent despite 
repeated changes of solutions and alterations in frequency and 
temperature over 6-10 hours of experimentation. Changes in muscle 
function over time would be anticipated. However, deterioration over 
time was compensated for by always referencing the response of either 
the control or shock peak to corresponding measurements made in a 
subsequent Krebs-Henseleit solution. 
This study was conducted to evaluate the influence of temperature 
and frequency upon the response of isotonically contracting canine 
papillary muscles to a chromatographic fraction of a pancreatic 
homogenate previously subjected to shock or control conditions. The 
control homogenate peak did not alter any of the measured parameters 
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except to cause some improved function relative to the response in 
Krebs-Henseleit solution. The shock horaogenate peak significantly 
depressed maximum load, both contraction and relaxation velocity, and 
the time to peak contraction (TPC). These effects appear to be 
influenced by the temperature and frequency of the muscle preparation. 
The results are consistent with a more pronounced effect of the shock 
peak at physiological temperature. A similar observation was reported 
by Williams et al. (1969). They observed depression of peak developed 
isometric tension and the maximum rate of tension development at 57 C 
but not at 30 C in response to dialysates of shock plasma. The time to 
peak tension was not altered in their study. Increasing the frequency 
of the muscle preparation in the present study appeared to antagonize 
the depressant effects on velocity and the TPC but not necessarily 
maximum load. This study reinforces the need to evaluate potential 
temperature and frequency effects on in vitro bioassay system used to 
evaluate inotropic agents. Further, it is possible that previously 
reported failures to detect an endogenous depressant factor with in 
vitro preparations may have been obscured by the inappropriate 
combination of these factors. 
The present study was conducted over a three month period but was 
not begun until six months after the homogenates had been collected and 
stored. Loss of activity with storage was not evaluated, yet measurable 
depressant activity was still possible. There were differences in the 
magnitude of depression observed in the numerous studies of Lefer and 
colleagues. Lefer typically reported 50-70^ depression of peak 
developed isometric tension, the primary criteria for assessing the 
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depressant effect of myocardial depressant factor. In contrast, maximum 
load was depressed by 15-25% in these studies- A concentration effect, 
differences in the preparation of the pancreatic specimens, use of 
different species for the bioassay system, use of isometric versus an 
isotonic preparation, or even the age of the preparation could account 
for these differences. 
It is not possible to identify the depressant factor in the present 
study as Lefer's myocardial depressant factor. However, there is no 
reason to believe that it may not be MDF. It was pancreatic in origin, 
prepared and processed by similar techniques, has a molecular weight 
between 500-1000, and depresses isolated isotonically contracting canine 
myocardium. 
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GENERAL DISCUSSION AND CONCLUSIONS 
Methods comparable to those employed by Lefer and colleagues were 
used to evaluate fresh whole shock plasma and pancreatic homogenates for 
the presence of a myocardial depressant. Although the canine has been 
utilized as a source for Lefer's myocardial depressant factor, a 
depressant effect has not been confirmed with an in vitro canine 
papillary preparation until the present study. 
The following conclusions were made from the results of these 
individual studies to evaluate the depressant effects of an endogenous 
myocardial depressant factor. Whole fresh shock plasma obtained from 
dogs subjected to hemorrhagic shock, but not control plasma, 
significantly depressed the rate of muscle shortening and relaxation of 
isotonically contracting canine papillary muscles but not the ability to 
shorten against a maximum load. A subsequent study was conducted to 
generate a depressant substance by incubating canine pancreatic 
homogenates under shock-like conditions. The homogenates were 
subsequently fractionated by gel chromatography and various molecular 
weight fractions evaluated for myocardial depressant effects with an 
isometric preparation of canine papillary muscle. Significant 
depressant activity was localized in a chromatographic peak with a 
molecular weight between 500-1000. The effects of that peak assayed at 
37 C and a frequency of 60/minute were to depress developed tension, 
both the rate of tension developed and the rate of relaxation (decline 
in tension), and to prolong the time to onset of contraction (latency) 
and the time to the maximum rate of relaxation. Temperature effects on 
isometric muscle function were evaluated in a third study. Cooling of 
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the preparation from 57 C to 27 C caused significant increases in 
developed or active tension but not resting tension. Each of the 
respective measurements of the time intervals recorded (LAT, TMVC, TPC, 
TMVR, and DUR) were all prolonged by cooling. The rate of relaxation 
was reduced by cooling, but insufficent data were obtained to confirm 
statistical significance. 
The influence of combinations of temperature and frequency on the 
isotonic response of cardiac muscle was evaluated in the final phase of 
this project. Cooling had a significant inotropic effect at both a 
frequency of 12 and 60/minute. An inotropic effect due to a faster 
frequency of stimulation was only observed at 37 C. Both contraction 
and relaxation velocity were also increased but only at 27 C. 
Increasing the frequency antagonized the slowing effect of cooling on 
all of the time intervals. The control homogenate chromatographic peak 
had no significant negative effects on muscle function at any 
combination of temperature or frequency. In contrast, the shock 
homogenate peak depressed function. This depression was influenced by 
temperature and frequency. Cooling reduced the magnitude of depression 
of maximum load. 
Relaxation velocity was the single measured parameter which was 
consistently depressed throughout all phases of this study. 
Unfortunately, little research has been previously done to better our 
understanding of the process. Most of the significant studies have only 
been done in the last decade by Strauer (1975), Strobeck et al. (1975), 
Tamiya et al. (1977), Brutsaert et al. (1978), and LeCarpentier et al. 
(1979). The observed load dependence confirmed these prior studies. 
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Further, the rather unique load-relaxation velocity relationship 
described by Strauer (1975) and Strobeck et al. (1975) with maximum 
relaxation at approximately 0.3Po was also observed. If cardiac 
relaxation in the intact individual is inhibited, then diastolic filling 
would be reduced. This may be the pathway by which the endogenous 
depressant factors compromises cardiac output and ultimately leads to 
irreversible shock. Relaxation would appear to be a parameter for 
future evaluation of shock factors. 
Further studies are necessary before the mechanism of action of the 
depressant factor can be elucidated. Although it is speculative, these 
results may suggest that the site of action is intracellular. Sucn a 
site is supported by the following observations. A site of action at 
the sarcolemma could alter the onset of contraction by modifying the 
action potential or inhibiting the transsarcolemmal pulse of trigger 
calcium necessary to induce calcium release by the sarcoplasmic 
reticulum. In the last study in which temperature and frequency effects 
were evaluated, latency tended to be slower but was significantly 
altered only at a narrow range of afterloads and then only at low 
temperature and frequency. However, latency was prolonged in the 
isometric screen of the chromatographed peaks. Second, relaxation 
velocity is more depressed than shortening velocity. Either slower 
cross-bridge turnover or impaired calcium uptake by the sarcoplasmic 
reticulum could produce such a response. Alternately, if less calcium 
were released by the sarcoplasmic reticulum, fewer cross-bridges would 
be formed and less tension would be generated. An uninhibited 
sarcoplasmic reticulum would sequester the reduced quantity of 
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sarcoplasmic calcium faster and the rate of muscle lengthening or 
relaxation would be faster. Contraction velocity is also depressed 
which suggests that the depressant must affect a common step in both 
processes. No effect on peak developed isometric tension was observed 
in the isometric experiments nor was any change in maximum load observed 
in response to shock plasma. The depressant effect would appear to be 
independent of the number of cross-bridges formed but alter the rate of 
formation and turnover. 
Higher frequency was shown to antagonize the depression of 
relaxation velocity caused by the shock peak. This implies that 
relaxation, which is dependent on the reduction of sarcoplasmic calcium 
levels, is faster when the calcium is increased by a more rapid 
frequency. It is possible that the depressant factor could 
theoretically alter calcium affinity at a key binding site. 
Mobilization of more calcium at a faster frequency could overcome the 
affinity change. 
Future studies are necessary to further examine these speculative 
ideas concerning the mechanism of action of the depressant factor. Four 
distinct approaches need to be followed. First, a metabolic effect of 
the depressant might be qualitatively assessed by measuring oxygen 
consumption in response to the depressant. This approached has been 
previously considered by Dr. F.B. Hembrough. A biochemical approach 
might include assessing changes in calcium affinity of subcellular 
organelles or measuring changes in the transient sarcoplasmic calcium 
levels during a contractile cycle caused by the depressant. Biochemical 
purification of the depressant factors is perhaps the most essential 
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future requirement. Although Lefer and Rovetto (1970) have reported 
that MDF prolonged the duration of the action potential of feline 
myocardium, only limited electrophysiological studies were conducted. 
The electrophysiological effects of the depressant need to be 
reassessed. Finally, modification of the depressant response by various 
pharmacological agents, especially those which affect intracellular 
calcium could be evaluated with the current type of in vitro preparation 
of cardiac muscle. 
Use of preparations of isolated cardiac muscle does have definite 
limitations. Such experiments are extremely time consuming and the 
number of experiments which can be conducted over a period of time is 
therefore limited. Great variability between muscles is typically 
observed not only for canine papillary muscle in the present study, but 
also for the traditional feline preparation. Roy Goldfarb, who has been 
cited in this dissertation for publications pertaining to myocardial 
depressant factor, has personally communicated that the traditional 
isometric papillary muscle is being abandoned in his future work. He 
now believes that cell cultures of cardiac muscle will provide a uniform 
and large population of experimental units. All of the measurements in 
the present study had to be calculated by hand. This introduces 
inherent error and illustrates the need to develop an on-line analysis 
system which incorporates a computer. At least 8-15 hours of hand 
calculations were necessary for each hour of data collection. However, 
future studies by the current technology will continue to provide 
valuable new insights into the role and mechanism of endogenous 
depressant factors. 
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